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ABSTRACT 
The purpose of this research was to assess outcomes of the antiretroviral treatment 
intervention in Mankweng. The antiretroviral treatment intervention was conceived with 
the aim to reduce HIV transmission through viral load suppression. Literature has 
shown that viral load is used as a tool to measure the performance of the intervention 
and studies on viral load outcomes in rural settings of Limpopo are limited. For this 
reason, the research was focused on viral load suppression with the aim of (1) 
determining the proportion of adults with viral load suppression among people taking 
antiretroviral treatment for 12 months, and (2) identifying factors associated with failure 
to achieve viral load suppression among people on antiretroviral treatment for 12 
months.  
Binomial logistic regression model was used to identify factors associated with failure to 
suppress viral load. This study used the theory of change to interpret its findings as well 
as theories of behavioural planning and self-regulation models to understand the logic 
that underpins the theory of change. The findings revealed that the majority (78%) of 
adults achieved viral load suppression, and a quarter of the individuals failed to suppress 
the viral load. There was no significant difference in baseline characteristics between 
people who achieved viral load suppression and those who did not. In addition, males, 
with a low CD4 and opportunistic illnesses when in the primary disease stages were 
more likely to fail to suppress the viral load. Moreover, people who were initiated on a 
3-pill containing treatment and do not have social support were also likely to fail to 
achieve viral load suppression. Although the study showed a trend of likelihood towards 
failure to achieve viral load suppression, the estimates were not statistically significant.  
Theoretical arguments from this study suggest that failure to achieve viral load was 
attributed to poor adherence to treatment. This is supported by the logic that underpins 
the theory of change, in which the assumption of adherence was possibly violated. 
However, the results chain framework highlighted that the implementation of the 
intervention was effective as it led to good outcomes and an effective intervention. 
Drawing all this together, the study highlights the need for intensified adherence 
counseling during treatment in order to improve the performance of the intervention. 
Author: Ramatsobane Johanna Ledwaba, Thesis Title: Outcomes of the antiretroviral 
treatment intervention in Mankweng, Johannesburg, March 2016 
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1 INTRODUCTION TO THE RESEARCH 
 
1.1 Background 
Before getting to the research problem statement (Section 1.2.1) and consequently the 
purpose of this research (Section 1.2.2) as well as the research questions (Section 1.2.3), 
this chapter briefly introduces the terms that are used in conceptualising the research. 
Section 1.1.1 introduces the prevalence of HIV in South Africa while describing what 
HIV is. Section 1.1.2 introduces but briefly the HIV antiretroviral treatment 
intervention, as well as its conception, implementation and outcomes. Section 1.3 
introduces the study setting, Mankweng. 
1.1.1 The global HIV burden  
The Human Immunodeficiency Virus type 1 (HIV-1) originates from Chimpanzees 
living in tropical forests of Southern Cameroon (Zhu, Korber, Nahmias, Hooper, Sharp 
& Ho, 1998). HIV-1 is a major cause of Acquired Immune Deficiency Syndrome 
(AIDS), a disease that was first discovered in patients in the USA in 1981 (Sharp & 
Hahn, 2010). In South Africa, the first case of AIDS was recognised in 1982 from a 
white homosexual man who contracted the virus while in the USA (Ras, Simson, 
Anderson, Prozesky, & Hamersma, 1983). HIV cannot live outside the body, it is 
transmitted from person-to-person through unprotected sexual intercourse, sharing of 
contaminated injection and transmission from mother-to-child during pregnancy, 
delivery and breastfeeding (Cohen, Hellmann, Levy, DeCock, & Lange, 2008). When the 
person is infected with HIV, the immune system becomes weak (drop in CD4) making 
the person susceptible to opportunistic infections and resulting in death (Westley, 
Greene, Tarr, & Hawes, 2012). 
Since its inception three decades ago, HIV is widespread across the globe. The 
explosion is driven mainly by factors such as, older men having sexual relation with 
young females (Drimie, 2002; Gregson, Nyamukapa, Garnett, Mason, Zhuwau, Caraël, 
Chandiwana & Anderson, 2002; Shisana, Rehle, Simbayi, Zuma, Jooste, Zungu, 
Labadarios et al., 2014), commercial sex, migration, and multiple sexual partners 
(Drimie, 2002; Hanson & Hanson, 2008). HIV continues to be a global public health 
concern. By 2013, an estimated 36.9 million people were living with HIV, globally 
(UNAIDS, 2014). According to UNAIDS (2014) Sub-Saharan Africa remains the 
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epicentre of the HIV epidemic with an estimated 25.8 million people infected with HIV. 
Seventy-one per cent of global HIV infections are localised in Sub-Saharan Africa, with 
Southern Africa accounting for almost two-thirds of all people living with HIV/AIDS 
worldwide.  
Within the Southern Africa region, South Africa has the largest number of people 
infected with HIV (6.4 million, 12.2%) (Shisana et al., 2014). The overall HIV prevalence 
differs by province. In 2012, Kwazulu-Natal province had the highest HIV prevalence 
(16.9 per cent), while Western Cape, Northern Cape and Limpopo had the lowest HIV 
prevalence; 5.0 per cent, 7.4 per cent and 9.2 per cent, respectively (Shisana et al., 2014). 
1.1.2 The national antiretroviral treatment intervention 
Prior to 1994, the National AIDS Convention of South Africa (NACOSA) developed a 
comprehensive and progressive AIDS plan in 1993 to curb the spread of HIV. The plan 
was adopted in 1994 by the newly elected democratic government (Nattrass, 2008). 
However, the lack of political will, authoritarian leadership, and bureaucracy constrains 
and lack of collaboration between activists and government hampered the 
implementation of the AIDS policy (Johnson, 2004). Despite all the impediments, at the 
end, South Africa established a comprehensive AIDS policy that included rolling out 
antiretroviral treatment to all eligible people in 2004 ( Johnson, 2004).  
Just to put everything into perspective, the antiretroviral treatment is a combination of 
three or more antiretroviral (ARV) drugs administered to fight HIV by suppressing the 
virus (viral load suppression) (World Health Organisation (WHO), n.d). The principal 
goal of antiretroviral treatment is to improve patient health outcomes and prolong life 
expectancy (Goldschmidt & Dong, 2000). In addition, antiretroviral treatment reduces 
the risk of mother-to-child transmission of HIV through viral load suppression 
(Townsend, Cortina-Borja, Peckham, de Ruiter, Lyall & Tookey, 2008). This AIDS 
policy was implemented using the National Strategic Plan (NSP). The current National 
Strategic Plan for HIV, TB and STIs 2012-2016 is a build up from the previous two 
NSPs (2000-2006 and 2007-2011), and its goal is to start 80 per cent of people living 
with HIV on antiretroviral treatment plan and have 70 per cent in care for 5 years post-
initiation. Currently, South Africa has the largest and the most comprehensive 
antiretroviral treatment intervention worldwide, in which over 2 million people were on 
antiretroviral treatment by end of 2014 (Johnson, 2012; UNAIDS, 2014).  
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1.1.3 Mankweng  
Mankweng is a semi-rural area found in Limpopo Province. It is situated in the 
Capricorn District 30 kilometres east of Polokwane city (City of Polokwane, n.d). 
Mankweng is made up of a township and six surrounding villages with an estimated 
population size of 33 738 in 2011 (Limpopo DoH, 2011). The area has a large tertiary 
hospital and a university. Therefore, it attracts a lot of qualified experts and a large 
population of students from afar (Report of the Portfolio Committee on Health, 2011). 
The majority of HIV infected individuals in Mankweng receive care and treatment at a 
government funded facility, Phela-O-Phedise (POP) ARV clinic. The facility is located 
in Mankweng hospital (Info4Africa, n.d). It is the largest ARV treatment site in the 
Capricorn district with over 2 000 individuals on antiretroviral treatment. (Info4Africa, 
n.d). 
1.2 Assessing outcomes of the antiretroviral treatment 
intervention in Mankweng 
1.2.1 The research problem statement 
Improvements on outcomes of the antiretroviral treatment intervention require linkage 
of HIV diagnosed individuals to care, initiation on antiretroviral treatment, retention in 
care and viral load suppression (WHO, 2015). Failure to closely monitor these stages 
may lead to poor outcomes of the intervention. In the HIV continuum of care, 
retention in care and viral load suppression are the most critical outcomes as they are 
aligned with the intervention‘s goal of improving individual‘s health outcomes, and 
reducing HIV transmission (Cheever, 2007). In the context of monitoring and 
evaluation, the two outcomes also play a major role of measuring performance of the 
intervention (WHO, 2015). Data from the United States have showed low viral load 
suppression rates in people who are not retained in care (Doshi, Milberg, Isenberg, 
Matthews, Malitz, Matosky et al., 2014). This is concerning because viral load 
suppression plays a key role in improving individual‘s health and reducing HIV 
infections in a community (Cohen, Hellmann, Levy, DeCock & Lange, 2008). In South 
Africa, less encouraging viral load outcomes were previously reported (Fielding, 
Charalambous, Stenson, Pemba, Martin, Wood, Churchyard & Grant, 2008) and 
adherence to treatment was a major determinant of viral load suppression (Jobanputra, 
Parker, Azih, Okello, Maphalala, Kershberger et al., 2015). Other key factors described 
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elsewhere that influence viral load suppression include HIV disease progression and 
baseline viral load (Cescon, Cooper, Chan, Palmer, Klein, Machouf, Loutfy et al., 2011), 
loss to follow up (Saka, Landoh, Patassi, d‘Almeida, Singo, Gessner & Pitché, 2014) and 
early retention (Mugavero, Amico, Westfall, Crane, Zinski, Willig, Dombrowski et al., 
2012). However, determinants of the viral load suppression have not been extensively 
studied in rural parts of South Africa. Therefore, evaluation of viral load suppression is 
conducted in order to improve performance of the intervention by informing the 
intervention manager of the suppression rates in the community (McMahon, Elliott, 
Bertagnolio, Kubiak, & Jordan, 2013) and to influence informed decision making for 
public health planning.  
1.2.2 The research purpose statement 
The purpose of this study is to assess the outcomes of antiretroviral treatment 
intervention in Mankweng. This was achieved by determining proportions of adults with 
viral load suppression among people who have been taking antiretroviral treatment for 
12 months, and identifying factors associated with failure to achieve viral load 
suppression among people on antiretroviral treatment for 12 months. First, we reviewed 
literature to identify the knowledge gap and the theoretical framework used to interpret 
research findings. Second, we constructed and presented a robust results chain showing 
the link between inputs, activities, outputs, outcomes, and impact of the intervention. 
Third, we proposed a theory of change to assess whether the achieved change was 
influenced by the intervention. Fourth, we proposed a research strategy, a research 
design, research procedure and methods appropriate to assess the outcomes of the 
antiretroviral treatment intervention in Mankweng. Fifth, we collected and analysed 
data. Lastly, based on the findings, we used the theory of change and results chain to 
determine if at all the antiretroviral treatment intervention has achieved the desired 
outcome. We also used a theoretical framework that drives the logic that underpins the 
theory of change.  
1.2.3 The research questions 
1. What is the proportion of adults with viral load suppression among people taking 
antiretroviral treatment for 12 months? 
Hypothesis: There are high proportions of adults with viral load suppression among people taking 
antiretroviral treatment for 12 month. 
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2. What are the factors associated with failure to achieve viral load suppression among 
people on antiretroviral treatment for 12 months? 
Hypothesis: Multiple factors are associated with failure to achieve viral load suppression. 
1.3 Delimitations of the research 
Antiretroviral treatment outcomes include the two stages that form part of the HIV 
continuum of care, which is retention in care and viral load suppression (WHO, 2015). 
In addition, other scholars have focused on mortality as another outcome of the 
intervention (Braitstein, Brinkhof, Dabis, Schechter, Boulle, Miotti et al., 2006; Fox & 
Rosen, 2010). Literature has shown that viral load can be used; (1) to map the HIV 
burden at population level (also known as community viral load) (Castel, Befus, Willis, 
Griffin, West, Harder & Greenberg, 2012); (2) as a tool to measure performance and 
assess the efficacy of the antiretroviral treatment intervention (Montaner, Lima, Barrios, 
Yip, Wood, Kerr, Shannon, Harrigan, Hogg & Daly, 2010); (3) to inform public health 
surveillance (Das, Chu, Santos, Scheer, Vittinghoff, McFarland, Colfax, et al., 2010); and 
(4) as well as to measure fidelity of health care services (Ortega, Eiros, Labayru, 
Hernandez, Bou & de Lejarazu, 2003). For these reasons, this research‘s main focus is 
on the outcome viral load suppression. This study is situated in the field of monitoring 
and evaluation; however it is only delimited to evaluation. 
1.4 Justification of the research 
It is over a decade since the introduction of antiretroviral treatment intervention in 
South Africa, therefore it is necessary to start measuring progress towards outcomes and 
impact of the intervention. International evidence suggests that, community viral load 
suppression reduces HIV transmission (Das et al., 2010). In a country with the largest 
number of HIV infections in the world, this evidence encourages researchers to closely 
monitor and evaluate viral load outcomes, as this will detect potential individuals who 
are likely to transmit the virus if they are not retained in care thus reducing the risk of 
HIV transmission. The South African government has adopted the new UNAIDS 
treatment 90-90-90 targets, aimed at ending the HIV epidemic by 2030. The strategy 
aims to ensure that by 2020, 90 per cent of individuals living with HIV know their 
status, 90 per cent of those eligible are initiated on antiretroviral treatment and 90 per 
cent of people on antiretroviral treatment will have viral load suppression. The progress 
report on the National Strategic Plan 2012-2016 documented an overall 75 per cent viral 
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load suppression rate from various cohort studies (SANAC, 2014). Therefore, it is 
paramount to continue to monitor and evaluate viral load outcomes to highlight the 
performance of the intervention.  
1.5 Preface to the research report 
To this end, the report has six chapters. Following this introductory Chapter 1, Chapter 
2 sets out to achieve three objectives. First, to introduce HIV and its prevalence, 
detailing the national antiretroviral treatment intervention. Second, to develop a 
theoretical framework for interpreting the research findings. Lastly, to propose a 
conceptual framework that provides a roadmap on how the research is undertaken. 
Chapter 3 is set out to discuss and commit to a research strategy, design, procedure and 
methods. Lastly, the Chapter shares some reliability and validity measures as well as 
limitations of the research design. Chapter 4 is set out to describe and analyse the 
research data by discussing all the issues raised under the two research questions and a 
conclusion to the Chapter. Chapter 5 discusses the findings in chapter 4 using a 
theoretical framework proposed in Chapter 2. Finally, Chapter 6 presents the knowledge 
gained from undertaking this research. The chapter summarises and concludes the 
research as well as highlighting study limitations and recommendations. 
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2 LITERATURE REVIEW 
This chapter reviews the literature centred upon the research topic. It starts with a short 
description of the research setting (Section 2.1). Section 2.2 reflects upon the research 
problem that necessitated the conceptualisation of this study by highlighting the root 
causes and consequences, the extent of the problem globally, regionally and locally. The 
section further discusses the antiretroviral treatment intervention, its conception, 
implementation and outcomes. In Section 2.3, we review literature on the purpose, 
methods, findings and conclusions from past and current studies that have performed 
similar evaluations focusing on factors associated with the intervention outcomes. The 
research draws attention to limitations found in the past and current studies. Section 2.4, 
discusses the broad field of monitoring and evaluation giving prominence to the focal 
component under review that is outcomes evaluation. To be able to measure the 
outcomes of the intervention, Section 2.5, describes the key variables that may play a 
major role in assessing evaluation outcomes. In section 2.6, we discuss a theoretical 
framework that this study is founded upon. The last section 2.7, provides a roadmap on 
how the activities of this research will be performed to answer its two research 
questions: ―what is the proportion of adults with viral load suppression among people 
taking antiretroviral treatment for 12 months and what are the factors associated with 
failure to achieve viral load suppression among people on antiretroviral treatment for 12 
months?‖   
2.1 Introduction to the Capricorn District in Limpopo Province 
This section sought to describe thinly the population of Capricorn District and its socio-
economic status (Section 2.1.1). In Section 2.1.2, the research focuses on the 
demography, and economic profile, and access to health care services in Polokwane 
sub-district paying more attention to the study setting Mankweng.  
2.1.1 Demography and socio-economic profile 
Capricorn District is located in the central part of Limpopo Province (Capricorn 
District Municipality, 2013). According to Capricorn District Municipality (2012), the 
district occupies a surface area of 21 705 kilometers2 with an estimated population size 
of 1 261 463. The population is still young as the majority of the people are aged below 
30 years. Capricorn district has the most educated population in the province with only 
13 per cent of individuals aged 20 and above without formal education. Despite the 
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district having the third largest economy in the province, there is a high rate of 
unemployment (37.2 per cent) especially among the youth (47.4 per cent).  
Figure 1 shows the district demarcations of Limpopo province after the apartheid 
regime. In 1996, the new South African constitution set a vision of local government to 
provide an equitable and effective public service delivery. It went on to draw district and 
sub-district boundaries. The Capricorn District is located at the centre of the province 
divided into five sub-districts, namely Aganang, Blouberg, Lepelle-Nkumpi, Molemole 
and Polokwane in the Capricorn District. The study setting, Mankweng is situated in 
Polokwane local municipality, 30 kilometers east of Polokwane city centre. 
 
Figure 1: Five local municipalities within the Capricorn District 
(Source: local government.co.za) 
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2.1.2 Polokwane sub-district 
Demography and socio-economic status 
Polokwane local municipality is located within the Capricorn district with an estimated 
population of 642 183 occupying three per cent of the total surface area of the province 
(Polokwane municipality, 2014). The Polokwane Municipality (2014) reported that this 
sub-district is predominantly comprised of Sepedi speaking black Africans followed by 
Afrikaans and English speaking whites, then coloureds and Indians (Polokwane local 
municipality annual report 2013-2014). The report highlighted that the sub-district 
serves as the economic hub of the province. It consists of 38 wards with a large 
population living in rural (71 per cent) or semi-urban areas, which for most part is under 
developed. The community service sector, comprised of local economic development, 
infrastructure and community upliftment projects, is the main contributor (32.1 per 
cent) towards the province‘s economy followed by the finance sector (21.5 per cent). By 
end of 2012, unemployment rates decreased from 19 per cent in 2009 to 16 per cent.  
Access to health care 
The DoH annual performance plan (2011), explicitly reported that health care service 
delivery in the Polokwane sub-district is provided via three regional hospitals, of which, 
two of them function as tertiary hospitals that form the Polokwane-Mankweng Hospital 
Complex. In addition, the complex is supported by one district hospital, Seshego 
Hospital, and one primary health care facility. In addition, there are over 40 primary 
health care clinics networked with all the three hospitals that send referrals to either of 
the hospitals.  
2.1.2.1 Mankweng  
Mankweng is a rural area situated 30 kilometres east of Polokwane (Limpopo DoH, 
2011). In 2011, it had an estimated population size of 33 738. It is made up of a 
township surrounded by six villages, namely, Dikgale, Mamabolo, Mamabolo-Segopje, 
Molepo, Mothiba, and Mothapo (Limpopo DoH, 2011). The area has a large tertiary 
hospital and a university; it therefore attracts a lot of qualified experts (Limpopo DoH, 
2011). The university and the hospital offer employment to its residents as well. 
HIV infected individuals in the area receive care and treatment at a government funded 
facility, Phela-O-Phedise ARV clinic, which is located in the hospital. It is the largest 
HIV treatment site in the district with over 2 000 patients on antiretroviral treatment.  
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2.2 The history and description of Human Immunodeficiency 
Virus – 1 (HIV) epidemic and interventions  
Here, the research undertakes a research problem analysis to understand the history and 
description of the HIV epidemic and interventions. Section 2.2.1 defines the origin of 
HIV and how it is spread. In this section, the study highlights the epidemiology of HIV; 
globally, in the Sub-Saharan region focusing on South Africa. The section also highlights 
the root causes and consequences of HIV. Section 2.2.2 discusses the antiretroviral 
treatment intervention initiated to curb the spread of HIV, focusing on the 
development of the AIDS policy, its implementation and outcomes. Section 2.3 reviews 
previous and current studies that have conducted similar research, focussed on the 
purpose, theoretical frameworks, methods, analysis, results and conclusions. 
2.2.1 The global HIV epidemic   
Human immunodeficiency virus (HIV) causes acquired immunodeficiency syndrome 
(AIDS), a disease of the human immune system (Sharp & Hahn, 2010). HIV is a 
contagious illness transmitted through coitus, mother-to-child during pregnancy, 
delivery and breastfeeding and through blood transfusions (Cohen et al., 2008). AIDS 
was first discovered in 1981 in the United States of America among men who have sex 
with men, and later HIV was identified (Sharp & Hahn, 2010). In South Africa, the first 
HIV case was identified in a homosexual man who travelled to the United States of 
America in 1982 and was diagnosed HIV positive upon his return (Ras, Simson, 
Anderson, Prozesky & Hamersma, 1983).  
HIV is widespread to all parts of the world causing suffering to human beings. By end 
of 2014, there were an estimated 36.9 million people living with HIV, globally, of whom 
2 million became newly infected with HIV down from 3.1 million in 2000 (UNAIDS, 
2014). Over 1 million people died of AIDS-related illnesses in 2014, a decrease by 2 
million from 2005 (UNAIDS, 2014). In view of the alarming HIV statistics, there is 
evidence of disparities in the number of HIV infections in the world, in particular 
Africa. Sub-Saharan Africa bears the brunt of the HIV disease with 79 per cent (25.8 
million) of global infections concentrated in this region, while two-thirds of the 
infections are localised in Southern Africa. Among 79 per cent infections in Sub-
Saharan Africa, 48 per cent are women and 5.4 per cent are children UNAIDS (2014). 
In the same year, 790 000 people died of AIDS-related causes in Sub-Saharan Africa, a 
fall by 48 per cent compared to 2004.  
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In South Africa, by end of 2013, there were 6.4 million people living with HIV —
making South Africa a country with the largest number of people infected with HIV 
compared to the world (Shisana et al., 2014). In 2012, an overall HIV prevalence of 29.5 
per cent among pregnant women attending antenatal clinics was recorded (DoH, 2013) 
and 16.9 per cent of HIV prevalence was observed in the population. Figure 2 illustrates 
the 2012 HIV prevalence aggregated by province. The Kwazulu-Natal province had the 
highest HIV prevalence (16.9%) (Shisana et al., 2014) while Western Cape, Northern 
Cape and Limpopo remain the lowest provinces affected by HIV. Limpopo has 
remained in the low end of HIV prevalence ranking since 2010. This trend 
demonstrates stabilisation of the HIV epidemic in the northern part of the country. 
Figure 2 illustrates the HIV prevalence by province. The findings are from the national 
HIV incidence survey. Kwazulu-Natal is the most affected province, and Western Cape, 
Northern Cape and Limpopo have the lowest HIV prevalence.  
 
Figure 2: Overall HIV prevalence in South Africa in 2012  
(Source: Shisana et al, 2014) 
Across all the provinces, HIV prevalence is at its highest peak in young aged population 
of 15 to 34 years, in particular female adolescents aged 15 to 19 years (DoH, 2013). This 
is corroborated by the findings from the national HIV prevalence, incidence and 
behaviour survey (Shisana et al., 2014). Literature also reported that young women are 
more likely to acquire HIV infection compared to young men, also female adolescents 
in relationship with older men have a greater chance of being infected with HIV 
(Pettifor, Rees, Kleinschmidt, Steffenson, MacPhail, Hlongwa-Madikizela et al., 2005). 
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2.2.1.1  Root causes and consequences of HIV 
A growing body of evidence purport that HIV is mainly a behavioural disease subject to 
environmental influence by factors that potentially drive the widespread of HIV in the 
region (Drimie, 2002). Through literature review, we found that the following symptoms 
authenticate challenges faced by HIV interventions. Such symptoms included female 
adolescence engaging in sex with older men who are more likely to be infected with 
HIV compared to young men in exchange of basic necessities (Drimie, 2002; Gregson 
et al., 2002; Shisana et al., 2014), commercial sex, migration, and multiple sexual partners 
that create sexual networks among communities further advancing the spread of HIV 
(Drimie, 2002; Hanson & Hanson, 2008). Another critical driver of HIV infections is 
gender imbalance, which leaves women vulnerable to HIV because they fail to negotiate 
safe sex as men refuse to use condoms (Langen, 2007).  
Existing literature has shown challenges associated with HIV interventions. However, it 
is critical that HIV interventions move beyond exclusively targeting the so-called risky 
behaviours of the key populations to also address the root causes of the symptoms that 
make HIV interventions impossible (Drimie, 2002). Studies have shown that poverty 
and inequality are the main root causes of vulnerability to HIV infections 
(Mbirimtengerenji, 2007; Parkhurst, 2010). A number of authors have suggested that 
poverty can increase susceptibility to HIV infection through commercial sex, inferior 
health care, increased labour migration and the associated risk of having multiple 
partners (Drimie, 2002; Mbirimtengerenji, 2007; Parkhurst, 2010). Drimie (2002) further 
argued that poor people living with HIV are susceptible to illnesses and experience early 
mortality than wealthy people due to malnutrition, poor health and lack of access to 
health care and medication. Moreover, different scholars appear to agree that, perhaps 
as a consequence of poverty from their own households, young women engage in sexual 
activities with older men in exchange of basic necessities (Drimie, 2002; 
Mbirimtengerenji, 2007; Parkhurst, 2010).  
On the other hand, Ghanotakis, Peacock, & Wilcher (2012) suggested that gender 
inequality influence vulnerability to HIV infection in women and girls. This was further 
explained by Ansari (2012) who observed that gender inequality manifests violence, 
stigma and discrimination against women, wherein women have no power over men to 
negotiate safe sex. The author further argued that stigma is another risk factor that 
potentially influences personal decision regarding HIV testing and disclosure. Similarly, 
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Magadi (2011) found that socioeconomically disadvantaged groups are most affected by 
HIV/AIDS. Similarly, a study conducted in the United States found that residential 
segregation, education and immigration are among the structural conditions that explain 
HIV/AIDS disparities among black communities (Denning & DiNenno, 2010). 
Therefore, poverty reduction and elimination of structural inequalities are key targets for 
improving efficacy of HIV interventions. 
Despite all the sufferings caused by HIV globally, the other negative consequence of 
HIV/AIDS in Africa is the slowing down and to some extent reversal of social and 
economic development (Taraphdar, Chatterjee, Dasgupta, Saha & Mallik et al., 2011). 
An impact evaluation by Drimie (2002) indicated that HIV and AIDS-related mortality 
have disproportionately affected women and children due to gender inequality and 
mother-to-child transmissions, respectively. One important indicator of the impact of 
HIV/AIDS is the increased dependency ratio among children and the elders (>60 
years). The increased child dependency ratio is a consequence of AIDS-related deaths 
among young adults, giving rise to the number of orphans that ultimately led to the rise 
in child-headed households. Furthermore, as a result of the epidemic, the public sector 
health systems are significantly overwhelmed due to increased demand of health services 
(Drimie, 2002; Kaul, Makadzange, & Rowland-Jones, 2000). According to Drimie 
(2002), the effects of HIV/AIDS towards the economic development include shortage 
of labour force and lower productivity due to absenteeism and illness. Economic 
consequences of HIV suggest that the economic growth will decline because funds will 
be shifted away from savings to cover the costs of illness (Drimie, 2002).  
In summary, South Africa remains the epicentre of the HIV epidemic with young 
women being the most affected population. Risky sexual behaviours influence HIV 
transmission creating obstacles towards HIV interventions, and further hampering 
efforts to cope with the impact of the epidemic. Regrettably, HIV has left crippling 
economies and orphaned children in many African countries. Ultimately, Africa has to 
develop interventions that will recognise culture norms and traditions and to also 
address the predictors of poverty as to maximally fight the scourge of HIV.  
2.2.2 The antiretroviral treatment (ART) intervention 
In response to the HIV epidemic, HIV interventions focused on prevention, diagnosis 
and treatment were initiated (Drimie, 2002). These were labelled as priority 
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interventions by the World Health Organisation as they offer a comprehensive response 
to the HIV epidemic (WHO, 2010).  
Although the South African apartheid government did very little to curb HIV, the new 
democratic government lacked the political will to promptly respond and develop an 
HIV/AIDS policy —this delay contributed towards the massive HIV explosion (Nunn, 
Dickman, Nattrass, Cornwall, & Gruskin, 2012). It was only with the help of AIDS 
activists that South Africa made significant progress towards HIV/AIDS policy (Nunn, 
Dickman, Nattrass, Cornwall & Gruskin, 2012). In the end, the National AIDS 
Convention of South Africa‘s (NACOSA) AIDS Plan from 1993 was the first credible 
response to the HIV epidemic and it was first adopted by the newly elected democratic 
government in 1994 (Westley, Greene, Tarr & Hawes, 2012).  
After a long contestation of the AIDS policy between the government and AIDS 
activists the government finally introduced the HIV and AIDS Comprehensive Care, 
Management, and Treatment (CCMT) Plan in 2004 with a ―goal to provide 
comprehensive care and treatment for people living with HIV and AIDS and to 
facilitate the strengthening of the national health system in South Africa‖ (DoH, 2003, 
p. 24). The adoption of HIV and AIDS Care, management and treatment plan led to the 
development of the National Strategic Plan 2007-2011 that promoted access to 
antiretroviral treatment and reduction of HIV infections by half (Nattrass, 2008). The 
National Strategic Plan was developed to fast track implementation of the AIDS policy. 
The established CCMT plan was accompanied by a vertical monitoring and evaluation 
system to monitor the programme (Kawonga, Blaauw, & Fonn, 2012; DoH, 2004).  
UNAIDS (2014) estimated that 2.8 million of South Africans were accessing 
antiretroviral treatment by end of 2013, which makes South Africa‘s antiretroviral 
treatment intervention the largest in the world. Recently, the HIV continuum of care 
has become a key component of monitoring and evaluation of the antiretroviral 
treatment intervention, with emphasis on evaluation of linkage into care, retention of 
patients throughout the continuum and achievement of viral load suppression as 
outcomes of the intervention (Cheever, 2007). Viral load suppression can also be used 
as a measuring tool to improve performance of the intervention (McMahon, Elliott, 
Bertagnolio, Kubiak & Jordan, 2013).  
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2.3 Methods, data, findings, and conclusions of studies and 
evaluations on outcomes of the antiretroviral treatment intervention
   
This section reviews the methods, findings and conclusions from studies that were 
conducted in South Africa and elsewhere on outcomes of the antiretroviral treatment 
intervention. The section will also draw on limitations of the studies and highlighting the 
knowledge gap for this research. The section will first summarise studies that have 
focused on the viral load suppression, followed by mortality then retention and loss to 
follow up as outcomes of the antiretroviral treatment intervention.  
Fielding et al. (2008) reported risk factors for sub-optimal viral load outcomes at 12 
months among HIV-infected adults receiving antiretroviral treatment in a workplace-
based HIV care programme in South Africa. Data was extracted from an electronic 
database. This study was a quantitative study using a cross-sectional design. The study 
was conducted from 1 July 2004 to 31 March 2006. Determination of risk factors 
associated to suboptimal viral load suppression was done using a logistic regression 
model. The analysis revealed that close to three-quarters of patients achieved viral load 
suppression (<400 copies/ml) at 12 months. A multivariate analysis demonstrated that 
ten times decrease in viral load at six weeks was the strongest predictor for sub-optimal 
viral load suppression at 12 months. In addition, site of treatment delivery had a 
significant influence on viral load outcomes. High baseline viral load and advanced HIV 
progression were risk factors for suboptimal viral load suppression at 12 months. In 
conclusion, the above findings suggest further probing on factors influencing outcomes 
at health facilities to guide development of effective antiretroviral treatment 
interventions. 
Another study by Nachega, Hislop, Nguyen, Dowdy, Chaisson, Regensberg, Cotton & 
Maartens (2009) compared adherence and viral load outcomes in infected adolescents 
and adults enrolled in a large private sector HIV management program in Southern 
Africa. It was quantitative research strategy using cross-sectional design. The study 
evaluated records of HIV infected adults and infected adolescents who initiated 
antiretroviral treatment between January 1999 and August 2006. Viral load suppression 
at each time point was used as dependent variable in a log-liner model, with adolescent 
status as an independent variable. Both univariate and multivariate analysis were 
performed. Regarding missing data, the imputation by chained equations (ICE) 
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technique was employed in fewer than four per cent of adults and fewer than 10 per 
cent of adolescents. Cox proportional hazards model was utilised to evaluate the 
association between adolescent status and the time from viral load suppression to viral 
load rebound. A two-tailed p-value of <0.05 was considered statically significant. 
Fisher‘s exact test and the Wilcoxon rank-sum test were employed to compare binary 
and continuous variables, respectively. 
Fewer adolescents achieved 100 per cent adherence at each time point compared to 
adults (adolescents: 20.7 per cent at 6 months, 14.3 per cent at 12 months, 6.6 per cent 
at 24 months; adults: 40.5 per cent, 27.9 per cent, and 20.6 per cent at each time point, 
respectively; p<0.01). Patients who achieved optimal adherence were more likely to 
suppress the virus at 12 months, regardless of age. In addition, adolescents who 
achieved viral load suppression had a shorter time to viral rebound (adjusted hazard 
ratio 2.03; 95 per cent CI 1.31–3.13; p<0.003) compared to adults. The authors 
concluded that HIV-infected adolescents and young adults on antiretroviral treatment in 
Southern Africa have poorer adherence rates, low rates of viral load suppression, and 
high rate of viral load rebound after initial suppression than their adult counterparts. 
Limitations noted for the study were small sample size among the adolescents and 
failure to explore reasons for non-adherence. 
Cescon, Cooper, Chan, Palmer, Klein, Machouf, Loutfy, Raboud, Rachlis &Cescon, 
Cooper, Chan, Palmer, Klein, Machouf, Loutfy, Raboud, Rachlis & Ding et al ￼ sought 
to probe time to viral load suppression and also identify factors associated with viral 
load suppression among individuals receiving antiretroviral treatment in Canada. This 
was a quantitative study conducted using cross-sectional design. Data was extracted 
from medical files of patients who initiated treatment on or after 1 January 2000 and 
had their last viral load test prior 31 December 2008; however data was only collected 
from March 2008. The primary outcome measure was attainment of viral load 
suppression defined as viral load below 50 copies/ml. Categorical variables were 
compared between groups using Pearson X2 test or Fisher exact test while continuous 
variables were compared using Wilcoxon rank-sum test. Time to viral load suppression 
was analysed using Kaplan-Meier methods, and stratified life table were used to 
compare to suppression by drug class of initial therapy. The effects of covariant of time 
on viral load suppression were assessed using piecewise survival exponential models. 
Multivariate analysis was done to assess factors associated with viral load suppression. 
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Statistical significance was recognised by a two-sided p-value below 0.05.  ￼Cescon et al 
found the median time to suppression to be 4.55 months. Male patients of older age 
receiving treatment in Ontario, who had no history of injectable drug use, who were 
diagnosed with AIDS at initiation were most likely to suppress. Similarly, patients who 
had low baseline viral load were also likely to suppress. The study had three limitations. 
First, it is failure to generalise findings to entire Canadian HIV positive population. 
Second, there was a high chance of patient selection and clinic based selection bias. 
Lastly, there was missing data at some of the sites.  
Another study by Jobanputra, Parker, Azih, Okello, Maphalala, Kershberger, Khogali, 
Lujan, Antierens, Teck et al., (2015) investigated factors associated with detectable viral 
load, and viral re-suppression after enhanced adherence counselling in adults and 
children on ART in Swaziland. In addition, the authors sought to establish whether 
adherence counselling is associated with viral load suppression amongst patients who 
previously had detectable viral load. This was a quantitative study that used a cross-
sectional design. Data was extracted from laboratory records of patients who underwent 
viral load testing from 1st October 2012 to 31st March 2013. The study measured viral 
load suppression as outcome. Pearson‘s Chi Square test was employed to compare 
categorical variables while Kruskal-Wallis test was used to compare medians for 
continuous variables. A multivariate and bivariate logistic regression model was 
performed to assess factors associated with viral load suppression. Bivariate analysis 
revealed that being a child, longer time on antiretroviral treatment, WHO clinical stage 3 
and 4, and recent CD4 count fewer than 350 cells/mm3 were significant predictors for 
viral load detectability. Patients who had a detectable viral load at six months were more 
likely to re-suppress than those who underwent annual viral load monitoring. The 
multivariate model demonstrated that being a child, having an initial viral load between 
1000 and 50, 000 copies/ml and recent CD4+ count below 350 cells/mm3 were factors 
associated with virologic failure. Patients with high viral load who received adherence 
counselling were more likely to re-suppress than those who did not receive counselling. 
Issues such as data quality and missing data limited the study.  
Elul, Basinga, Nuwagaba-Biribonwoha, Saito, Horowitz, Nash, Mugabo, Mugisha, 
Rugigana & Nkunda (2013) conducted a study to determine predictors of optimal 
adherence and viral load suppression among patients receiving antiretroviral treatment 
in Rwanda. The researchers employed a quantitative research strategy. Data was 
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collected using chart abstraction, patient face-to-face interviews and site assessment 
from September 2008 to April 2009. Stratified multi-stage sampling was employed, with 
treatment sites as clusters and further stratified into six strata according to type of 
facility (public or faith based) and duration of antiretroviral treatment (6, 12 and 18 
months). Initial sampling included random selection of 14 public and 6 faith-based sites 
from 113 sites. During the second stage of sampling, patient registers and charts at 
selected sites were utilised to develop a sampling frame of all eligible patients in each 
strata. Potential participants were chosen from site-specific sampling frame using simple 
random sampling. Individual records were reviewed for each potential participant 
selected using random sampling to confirm that they met the study eligibility criteria. 
Descriptive statistics was employed to describe study sites and patient characteristics by 
time since the start of antiretroviral treatment. Logistic regression analysis was utilised to 
identify patient and site level characteristics associated with two of the outcomes: sub-
optimal 30-day adherence and detectable viral load. Of 837 patients who received viral 
load test 83% achieved viral load suppression. Regression models revealed that being on 
antiretroviral treatment for 18 months (versus 6 months), younger age, severe side 
effects in the prior 30 days (versus no or few), missing CD4+ cell count at antiretroviral 
treatment initiation (versus having a CD4 cell count of 200 cells/ml), alcohol use, 
attending sites that initiated antiretroviral treatment services in 2003-2004 and 2005, and 
sites with peer educators were more likely to have sub-optimal 30-day adherence. While 
participation in association for HIV-infected people, and receiving care at sites that 
conduct home visits were associated with lower odds of having non-adherence, and 
being female and using a reminder tool were associated with lower odds of high viral 
load. The authors observed high levels of optimal adherence and viral suppression in 
the Rwandan antiretroviral treatment intervention. The study prohibits the researchers 
from ruling out reverse causality due to the cross-sectional design used. 
Doshi et al. (2014) conducted a quantitative study assessing proportion of clients at 
critical stages of the HIV continuum of care and further examining factors associated 
with achieving retention in care and viral load suppression. The study employed a 
longitudinal design. Primary outcome variables were defined as retention in care and 
viral load suppression. Odds ratios and frequencies were calculated for outcome of each 
predictor variable. In 2011, over 500 000 clients sought health care services at an 
insurance-funded facility in the United States. Of these, 62 per cent attended at least one 
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medical visit. Of these, 82 per cent were retained in care, and 72 per cent achieved viral 
load suppression. Viral load suppression was higher among retained clients versus 
clients who were not retained. Low levels of retention and viral suppressions were 
among youth and young adults (13-34 years). A critical shortcoming for the study was 
missing data for viral load values. 
Another study by Fox et al. (2012) assessed antiretroviral treatment outcomes over seven 
years at an urban clinic in South Africa. This was a quantitative study that utilised a 
cross-sectional design, in which data was collected from April 2004 to March 2010. Data 
was retrieved from an electronic patient management system. About 90 per cent of 
patients on antiretroviral treatment achieved viral load suppression at 6 month and 
beyond. Much of the poor outcomes happened in the first year of treatment. The 
proportion of those who died within the first year on treatment was under 11 per cent at 
all calendar years, while the proportion lost by one year increased from 3.4 per cent in 
2004 to 12.1 per cent in 2009. The authors estimated that 25 per cent of patients were 
lost to follow up and 16 per cent died after seven years on antiretroviral treatment. The 
overall mortality rate was 3.51 per 100 person-year. Summarily, most patients 
suppressed the virus, and 76 per cent were retained in care after a year on treatment. 
One-year mortality was below 11 per cent. After the first 12 months on treatment, 
monthly rates of death and loss decreased significantly and remained unchanged. The 
study experienced three shortcomings, first was missing data, second was 
misclassification of death and lastly, one clinic was not generalizable to all settings. 
Budgell, Maskew, Long, Sanne, & Fox (2015) conducted a study comparing death in 
patients who are retained in care and lost after the start of treatment and further 
assessed the sensitivity of estimates different definitions of loss to follow up. This was a 
quantitative study conducted using a cross-sectional design; in which data was 
prospectively collected among HIV-infected patients enrolled for antiretroviral 
treatment between April 2004 and May 2012. The primary outcome variable was 
mortality, defined as death either in care or lost after the start of treatment. The authors 
aggregated baseline clinical information and mortality by in care status. Further, 
mortality rate in care and lost was assessed with matching death rate differences 
attributable risk (AR %) with 95 per cent confidence interval. The cox proportional 
hazard models were employed to determine the relationship between in care status and 
all-cause mortality. Model analysis revealed that 14.6 per cent of patients who have died 
 29 
and being lost accounted for fewer proportions of deaths across multiple stages of loss 
to follow up. Even though, mortality rates in patients lost to follow up were superior to 
patients in care, most antiretroviral treatment -associated deaths occurred while on 
treatment. The drawbacks to this study were the misclassification of lost to follow up 
and non-differential misclassification of death. 
Wandeler, Keiser, Pfeiffer, Pestilli, Fritz, Labhardt, Mbofana, et al. (2012) evaluated 
outcomes of antiretroviral treatment intervention in rural settings of Southern Africa. 
The study was conducted to examine the significance of no loss to follow up, mortality 
and loss to follow up over three years on antiretroviral treatment in Zimbabwe, 
Mozambique and Lesotho. Data was retrieved from an electronic database between 
January 2005 and June 2010. The three outcome variables assessed were no loss to 
follow up after antiretroviral treatment initiation, loss to follow up (attrition) and death. 
Logistic regression model was used to determine factors associated with no loss to 
follow up after antiretroviral treatment initiation, no returning to facility after the start 
of antiretroviral treatment and further competing models were used to analyse loss to 
follow up and death. The analysis revealed high rates of mortality in loss to follow up. 
Young age and male gender were associated with the likelihood of no loss to follow up. 
Limitations identified in this study were biasness towards mortality rates and missing 
data. 
A quantitative study by Fatti, Grimwood, & Bock (2010) was conducted using a cross-
sectional design to relate baseline information and treatment outcomes between 
individuals who seek care and treatment at different levels in the health system. Data 
was collected between December 2001 and December 2007 at 59 health facilities in 
both urban and rural areas of South Africa. The outcome variables assessed were death, 
lost to follow up and viral load suppression. The Kaplan-Meier estimates, competing 
risks cox and logistic regression models were employed to compare death, loss to follow 
up and viral load suppression between primary health centre, district and regional 
hospitals. The authors found that patients receiving care at the primary health centre 
were very ill at the start of antiretroviral treatment. Retention in care was high at primary 
health centres, followed by district then regional hospitals. Loss to follow up was 
independently high at regional hospital, and mortality was also independently high at 
district hospital compared to primary health centre after 12 months on antiretroviral 
treatment. To sum up, antiretroviral treatment outcomes were superior at primary health 
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clinic facilities despite primary health clinic having more advanced clinical stage diseases 
when starting antiretroviral treatment. 
Nguyen, Do, Shiraishi, Le, Tran, Nguyen Medland et al. (2013) and colleagues 
conducted an evaluation study in Vietnam aimed to examine programmatic outcomes of 
HIV infected adults who are on antiretroviral treatment and factors associated with the 
outcomes. The evaluation used a cross-sectional design as data was abstracted from 
medical records of patients who initiated antiretroviral treatment between 2005 and 
2009. Retention proportions were calculated using stratified Kaplan Meier. Key factors 
associated with attrition were assessed using cox proportional hazards model. There was 
good retention of patients in the programme, further; other factors such as advanced 
disease stage, being male, low CD4 count were associated with attrition. The limitations 
for the study were missing data and failure to explore reasons for loss to follow up or 
cause of death. 
Another retrospective cross-sectional study by Saka et al. (2014) sought to determine 
factors associated with attrition was conducted in Togo. Data was abstracted from 
medical records of HIV-infected individuals on antiretroviral treatment who were lost to 
follow up between January 2008 and October 2011. The primary outcome variable was 
loss to follow up at six months or less compared to loss to follow up greater than six 
months. Medians and interquartile ranges were reported for continuous variables while 
proportions and respective 95 per cent confidence interval were reported for categorical 
variables. Multivariate logistic regression analysis was performed to determine risk 
factors for outcome loss to follow up or not lost to follow up. The multivariate analysis 
revealed age below 35 years, female sex, advanced HIV disease, presence of 
opportunistic infection as factors associated with early loss to follow up and confirmed 
high mortality in these patients. Predictors of early loss to follow up were age below 35 
years, presence of opportunistic infections at the start of antiretroviral treatment, living 
in rural area and receiving HIV treatment at public health system. Summarily, loss to 
follow up precedes advanced disease stage then death, explicitly among women and 
young adults. 
A quantitative study by Huang, Tan, Ma, Zheng, Lu, Wang et al. (2015) aimed to 
evaluate antiretroviral treatment outcomes in China. This study was conducted between 
2003 and 2014. Huang and colleagues used Chi-Squared test-to-test categorical variables 
while Mann-Whitney was used for interval data. Survival rates were tested using Log 
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rank test, while the Cox model was used to assess possible risk factors. Eighteen per 
cent of the patients had a detectable viral load. In addition, baseline viral load, clinical 
stage IV were significantly associated with failure to suppress viral load. The strongest 
risk factor low CD4 count and clinical stage IV. Patients who were on treatment for 
long (10 years) maintained viral load suppression and low mortality.  
Another study by Syed, Sulaiman, Hassali, Syed, Shan & Lee (2015) sought to determine 
factors associated with poor viral load and immunological outcomes in Malaysia. Syed 
and colleagues employed a quantitative strategy and a cross-sectional design to answer 
their research questions. The study was conducted between July and October 2012. 
Data was sourced using face-to-face interviews and extraction of information from 
patient medical records to a questionnaire. Chi-squared test was employed to determine 
the relationship between categorical variables. Comparison between two groups with 
normally distributed data was performed using student t-test and one-way ANOVA. 
Pearson correlation test was conducted to assess correlation between mean scores. Drug 
toxicity and co-morbidity was associated with poor immunological and viral load 
outcomes.  
Another study conducted by Mutevedzi, Lessells, Heller, Bärnighausen, Cooke & 
Newell (2010) in rural Kwazulu-Natal sought to evaluate trends in baseline 
characteristics and antiretroviral treatment intervention. The study was conducted on 
adults who initiated treatment between October 2004 and September 2008. The study 
assessed retention in care, loss to follow up, mortality and viral load outcomes. Data was 
collected from a database using a questionnaire. Regression analysis was used to 
compare groups. Survival analysis was performed to assess trends in time death and viral 
load suppression. Cox model was also used to determine factors associated with death 
and viral load suppression. Overall, mortality occurred in the first three months of 
antiretroviral treatment and 23 per cent had a detectable viral load. Retention was high 
at 84 per cent, 10 per cent died, 3.7 per cent were loss to follow up. Outcomes were not 
influenced by the expanding decentralised antiretroviral treatment intervention. 
Nglazi, Lawn, Kaplan, Kranzer, Orrell, Wood & Bekker (2011) performed a quantitative 
study in Cape Town between September 2002 and September 2009 aimed at evaluating 
trends in mortality and attrition. Data was collected using a questionnaire to transfer 
information from the database. Survival analysis was done to determine time to event. 
Log rank test was done to compare time to event after the start of antiretroviral 
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treatment. Cox proportional model was employed to determine the hazard of the event. 
After six years of antiretroviral treatment enrolment the probability to death and loss to 
follow up was estimated at 37 per cent, failure to achieve viral load suppression was 23 
per cent. There were fewer death risks and good immunological and virological 
outcomes in the first 12 months of the start of antiretroviral treatment. However, loss to 
follow up and failure to achieve viral load suppression increased between successive 
calendar years. The findings show successful antiretroviral treatment outcomes in the 
early years of the antiretroviral treatment rollout. 
All of the above reviewed studies used a quantitative strategy to evaluate outcomes of 
the antiretroviral treatment intervention around the world. A cross-sectional design was 
popular in such evaluations together with the use of multivariate logistic regression 
model to determine factors associated with the outcomes. The reviewed studies 
highlighted key factors associated with likelihood of achieving viral load suppression. 
Such factors included being an adult, female gender, low baseline viral load, using a 
reminder tool, participating in a group of people living with HIV, and attending clinics 
that do home visits. It was proven that children and adolescents are more prone to 
having high viral loads making it unlikely to achieve viral load suppression. Rather, there 
is general consensus that failure to achieve viral load suppression is largely attributed to 
non-adherence to long term HIV treatment. Low rates of viral load suppression were 
observed in patients who were not in care while retention rates were higher after a year 
of treatment and decreased afterwards. The low rates of retention pose a threat to 
sustainability of antiretroviral treatment in Sub-Saharan Africa, especially in rural areas. 
Similarly, high mortality rates were more common in patients who were lost to follow 
up. Missing data was a common limitation identified in all the studies. There are limited 
studies that evaluated outcomes of the antiretroviral treatment interventions in rural 
areas of Limpopo Province, and none of them have used a theoretical framework to 
interpret the findings.  
2.4 An introduction to monitoring and evaluation studies 
Section 2.4.1 describes the concept overview of monitoring and evaluation by further 
describing components of evaluation (Section 2.4.2) while highlighting the main purpose 
of evaluation (Section 2.4.3). In Section 2.4.4 the research emphasises the key steps 
followed when undertaking an evaluation and it also shares the key debates around 
evaluation (Section 2.4.5).   
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2.4.1 Describing monitoring and evaluation 
There is increasing evidence showing that monitoring and evaluation (M & E) play a 
significant role in development, worldwide. It is a tool adopted by governments and 
organisations to improve accountability, effectiveness and efficiency (Kusek & Rist, 
2004). In development, monitoring and evaluation is essentially utilised to monitor 
activities of interventions while promoting learning consequently providing improved 
performance and achievement of results of the intervention (Görgens-Albino & Kusek, 
2009; Holvoet & Inberg, 2014). Guerra-López & Hicks (2015) purport that monitoring 
and evaluation can influence policy and planning of interventions.  
Figure 3 demonstrates two distinct beasts, monitoring and evaluation and how they 
complement each other. Monitoring and evaluation is anchored on four components 
that enable the whole system to function— thus monitoring, formative evaluation, 
process evaluation and summative evaluation. The monitoring component is essentially 
concerned about collection of data or information through indicators that are designed 
to supply information by means of tracking activities and monitoring for results (Bhana 
& Govender, 2010). Further, Kusek & Rist (2004) sub-divided monitoring into two 
levels, implementation monitoring and results monitoring. The two levels are both 
responsible for tracking of results. The authors further describe implementation 
monitoring as tracking inputs, activities and outputs utilised to attain an intended 
outcome while results monitoring focus on alignment of outputs with the intended 
results of the intervention. The remaining three components are housed under the main 
component of evaluation. Bhana & Govender (2010) purport that evaluation can be 
performed at the final stage of an evaluation in a systematic approach seeking to 
improve interventions (formative) or making a judgment about the worth of and 
effectiveness of an intervention.  
 
Figure 3: Schematic representation of monitoring and evaluation field highlighting its 
components and sub-components.  
Monitoring Evaluation
Formative Process Summative
Outcome Impact
Monitoring and evaluation
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Ongoing debates in monitoring and evaluation are focused on methodological 
approaches employed to conduct an evaluation (Lucas & Longhurst, 2010), how to 
accurately measure and correlate successes of the intervention (Tsui, Hearn, & Young, 
2014). The debates are also focussed on data use, as it may improve service delivery, 
thereby maximising intervention outcomes and informing evidence-based decision 
making (Patton, 2008). Some scholars base their arguments on attribution and 
contribution (White, 2010) and utilisation of monitoring and evaluation to understand 
causality (Guerra-López, 2012). The tension between accountability and learning is often 
highlighted in literature (Shutt, 2011). 
2.4.2 Describing evaluation 
According to Patton (2008, p. 5)  to evaluate something is ―determining its merit, worth, 
value or significance‖. There are three main goals for evaluation reported, that is, to 
measure, understand and learn (Berriet-Solliec, Labarthe, & Laurent, 2014). Others view 
evaluation as a tool used to improve design and operations of interventions in order to 
promote continuation or cessation of an intervention or even support the intervention 
(Stoltzfus & Pillai, 2002). In essence, evaluations are used to measure the effectiveness, 
appropriateness, acceptability and efficiency of interventions (Stoller & Rutherford, 
1989). 
2.4.3 The purpose of evaluation 
The main purpose of evaluation is to assess the effectiveness of an intervention. 
However, Berriet-Solliec et al., (2014) assume that the three main goals for evaluation is 
to measure, understand and learn. According to Berriet-Solliec et al. (2014), ‗measuring‘ 
—here the focus of an evaluation is to determine whether an intervention has produced 
the anticipated results given the resources at disposal. The goal of ‗understanding‘ —an 
evaluation is conducted to assess the underlying theory of the intervention to be able to 
produce the anticipated results. Lastly, evaluation is done for learning processes as it is 
meant to improve on current and future interventions. It can further assist decision 
makers to adapt the need for evaluation (the why) into an appropriate design (the how) 
(Habicht, Victora, & Vaughan, 1999), hence at times it is also conducted to select a 
proper design. After all, the overarching goal is to utilise the data generated to inform 
decision-making that leads to improved performance (Guerra-López, 2012). 
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2.4.4 Major components of evaluation 
To ensure that interventions deliver effective and efficient information, evaluation of all 
the stages of the intervention is important. Stoller & Rutherford (1989) suggested that a 
thorough evaluation must entail assessment of events at various stages of developing 
and implementing an intervention. These different measures include the three forms of 
evaluation that succeed one another —formative, process and summative evaluation 
(Stoller & Rutherford, 1989; Wimbush, Montague, & Mulherin, 2012).  
Formative evaluation is focused on interventions that are under development. Different 
scholars agree that formative evaluation is conducted during the planning phase to 
identify research gaps by means of needs assessment, it also involve elements such as 
the programme logic model (Bhana & Govender, 2010; Stetler, Legro, Wallace, 
Bowman, Guihan, Hagedorn & Kimmel et al., 2006; Stoller & Rutherford, 1989). 
Further,  Stetler et al., (2006) argue that formative evaluation is important because it 
offers researchers an opportunity to study factors that may affect implementation of the 
programme as it provides important data about the implementation. These factors 
include (a) the extent of unaccomplished standard of practice (b) factors associated with 
the existing practice (c) potential barriers towards practice changes and implementation 
of the adopted strategy (d) and strategy feasibility (Stetler et al., 2006). It is performed 
specifically to improve plans and implementation as to achieve intervention results 
(Bhana & Govender, 2010; Stoller & Rutherford, 1989). 
Process evaluation assesses fidelity to ensure that implementation of interventions is 
done according to the plan (Bhana & Govender, 2010; Linnan & Steckler, 2002). It 
emphasises implementation of an intervention by monitoring progress on activities 
while it provides information for planning and feedback on progress (Bhana & 
Govender, 2010; Stetler et al., 2006). There is general consensus that process evaluations 
assist in finding reasons why some of the intended outcomes were not realised, as it 
draws on the implementation conclusions of an intervention. If the conclusions are not 
detrimental, the intervention can be further developed and fine-tuned (Stoller & 
Rutherford, 1989).  
A summative evaluation focuses on interventions that are in progress or have been 
completed —by probing intervention‘s results (intended and unintended) (Bhana & 
Govender, 2010). It is also emphasised on measurements of performance and the 
effects of an initiative (Bhana & Govender, 2010; Stoller & Rutherford, 1989). The 
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purpose of a summative evaluation is to determine if results occurred and if they 
contribute to learning (Stetler et al., 2006; Wimbush et al., 2012). Findings from this type 
of evaluation are utilised to inform decisions about the evaluated intervention, as 
utilisation of data in evaluation is highly needed (Habicht, Victora & Vaughan, 1999). 
During summative evaluation outcomes that are being evaluated can be short-term —
also referred to as outcomes evaluation or long-term, referred to as an impact evaluation 
(Bhana & Govender, 2010). Bhana & Govender (2010) described that the purpose of 
outcomes evaluation is that of assistance with strategic intervention planning and 
influencing policy decisions. McNamara (1997) argues that outcomes evaluation seeks to 
assess progress by identifying gaps and improving implementation of the intervention. 
This imply that summative evaluation moves away from assessing intervention results 
against intervention objectives, towards assessing how these results have contributed to 
changes in HIV interventions. 
2.4.5 Major processes of evaluation 
Evaluation is comprised of three key steps; planning, implementation and utilisation of 
data. In accordance to Kellogg Foundation (2004), the planning phase focuses on 
setting of objectives and stakeholder analysis. Stakeholder analysis is identifying key 
people who are affected by the intervention, users of the intervention as well as people 
who are responsible for operations of the intervention. Implementation phase reflects 
on collection, analysis and interpretation of data. During this phase the evaluator must 
ensure continuous engagement with the involved community or stakeholders, that the 
evaluation meets its projected timelines, and check compliance to operating standards. 
Lastly, data generated during evaluation is used to improve the programme and generate 
knowledge.  
There are two key tools that are used to design an evaluation, namely, logic model and 
logical approach framework. The conception of a logic model is a fundamental initial 
step in every programme evaluation (Renger & Titcomb, 2002). It is developed during 
the planning phase where all stakeholders are involved in identifying intervention 
objectives responsible for driving the programme (Kellogg Foundation, 2004). The 
programme logic model provides a roadmap on how the intervention works. It unpacks 
the underlying theory of how the programme will function under predefined 
assumptions (McLaughlin & Jordan, 1999, 2004; Kellogg Foundation, 2004). Logic 
model provides hypothesis (a series of if-then statement) in order to check how the 
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intervention is supposed to function to be able to achieve the anticipated results, by 
reading ―if assumptions about contextual factors remain correct and the programme 
uses these resources with these activities, then it will produce these short-term outcomes 
for identified customers who will use them leading to longer term 
outcomes‖(McLaughlin & Jordan, 1999, p. 70).   
There are 3 types of logic models, namely, outcome model, activities model and the 
theory model (Kellogg Foundation, 2004). The outcome model is the commonly used 
model in evaluations and it is represented below. 
Figure 4 shows a schematic illustration of a logic model that can function under certain 
assumptions and risks to be able to solve a problem (Renger & Titcomb, 2002).  
 
Figure 4: Logic model 
Source: McLaughlin & Jordan, (1999, 2004) 
According to McLaughlin & Jordan, (1999, 2004) the elements of a logic model are: (a) 
resources— inputs needed to support the programme such as human and budget, (b) 
activities reflect action steps necessary to produce programme outputs, (c) outputs focus 
on goods and services provided to the intervention participants, (d) outcomes focus on 
changes resulting from activities and outputs provided by the programme and lastly (e) 
impact or longer term outcomes are benefits accumulated from outcomes. In sum, logic 
model links outcomes to programme activities (McLaughlin & Jordan, 2004).  
 The Logical Framework Approach (LFA) is another tool used during evaluation 
planning phase when the objectives and goals are being set. According to NORAD 
(1999) the logical framework approach was first employed in project management for 
planning and appraisals prior to its adoption into monitoring and evaluation field by 
donor agencies and their bi- or multilateral governments. Since its inception, the LFA 
development has evolved over the years, however the fundamentals and principles of 
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the log frame have remained the same. Crawford & Bryce (2003) purport that a log 
frame must include goals and objectives of an intervention; means of verification for 
each indicator level (Impact/outcomes/outputs/inputs); and the assumptions stating 
conditions by which the attainment of outcomes will be achieved (if-then causality). The 
log frames are no longer deemed relevant for measuring effectiveness, rather different 
scholars are taking the initiative of extending the currently used frameworks to assess 
the successes and fidelities of interventions (Diehl & Major, 2015).  
2.4.6 Established facts in evaluation 
There are key facts to be taken into consideration before conducting an evaluation. 
Evaluations are a knowledge base (Peersman & Rugg, 2004), they are conducted to 
answer questions of efficiency and effectiveness (Peersman, Rugg, Erkkola, Kiwango, & 
Yang, 2009). Through process evaluation, evaluation improves implementation of the 
intervention by increasing efficiency thereby highlighting its weaknesses in order to 
improve the intervention (Bhana & Govender, 2010; Stoller & Rutherford, 1989). 
Evaluations are used to verify whether the intervention is following the implementation 
plan thereby granting a full examination (adaptability, feasibility, plausibility and 
adequacy) —describing an effective intervention for duplication elsewhere (Habicht et 
al., 1999). The ability to generate data that will be meaningful and utilised for informed 
decision-making an evaluation must be designed during the planning phase of an 
intervention (Steckler, Linnan, & Israel, 2002; Stetler et al., 2006b). An evaluation is a 
critical means to discriminate successful interventions from those that are unsuccessful.  
Evaluations are conducted to verify impact or effects of the intervention on the 
beneficiaries (Habicht et al., 1999; Stoller & Rutherford, 1989).  
2.4.7 Key issues in the study of evaluation 
Recent debates are fixated on the credibility of evaluation results. The debate is largely 
focused on how to measure impact, whether or not experimental design in the form of 
randomized controlled trials are the most optimal way to provide credible evidence on 
the past performance of an evaluation rather than improving future performance 
evaluations using diverse methodologies (Gargani & Donaldson, 2011). The proponents 
of randomized controlled trials suggest the use of experimental design as a benchmark 
or gold-standard for evaluations (Bhana & Govender, 2010). However, evaluation 
practitioners do not always have time, resources or control over intervention design. De 
Lay & Manda (2004) argue that another key issue facing evaluation is political 
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interference, which is done by misusing data and lack of response towards evaluation 
results. However, De Lay & Manda (2004) suggest that this can be corrected by 
promoting adequate and appropriate use of data.  
Another difference is failure to articulate the theory of change that underpins each 
intervention (Edgington, 2010). Theory-based evaluation is highly recognised amongst 
theorists and evaluation practitioners. However, there is still challenges on how to apply 
this approach in practice and how to make valid deductions about contributions of 
certain interventions to observed changes (Nakrošis, 2014). According to White (2006), 
a theory-based approach focuses on efficiency (how an intervention is working), not just 
how it operates, and this requires both quantitative and qualitative data.  
2.5 Key attributes of an evaluation exercise 
This section discusses key variables that are involved in an evaluation of the 
antiretroviral treatment intervention. In monitoring and evaluation, variables function as 
indicators that are utilised to collect data by tracking change over time, identifying 
problem areas as well as to determine the effectiveness of the programme or monitor 
programme goals (WHO, 2015). Selection of indicators for an intervention is a cautious 
process, as the indicators have to be good and a good indicator must be SMART, 
Specific – Measurable – Achievable – Relevant – Time bound (Rajalahti, Woelcke, & 
Pehu, 2005). Monitoring indicators are used to measure inputs, processes and outputs in 
order to monitor the efficiency of the intervention (process evaluation) while evaluation 
indicators are aligned to outcomes and impact and are used to assess the effectiveness of 
the intervention (summative evaluation). 
2.5.1 The inputs 
Inputs are among the important elements of the planning phase of an evaluation and 
they are usually overlooked during evaluation processes (Nikkhah, Sharif, & Talebi, 
2011). Inputs are comprised of elements that are entered into the system in order to 
drive evaluation processes (Parsons, Gokey & Thornton, 2013). The inputs for the 
antiretroviral treatment intervention are budget, HIV policies and standardised 
treatment guidelines, antiretroviral treatment clinic stationery, human resource, 
antiretroviral drugs, equipment and infrastructure. One big challenge is to ensure that 
people who are initiated on antiretroviral treatment are maintained on treatment so they 
live longer and further participate in the economy. Sustainability of the intervention is 
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achieved by a large amount of money from the fiscus and budget; and expenditure is 
monitored using the medium term expenditure framework (DoH, 2004). South African 
government offers antiretroviral treatment for free in a public health approach; 
therefore it developed and implemented standardised treatment guidelines to use for 
patient management.  
2.5.2 The activities  
Activities focus on actions or processes, that is, what needs to be done to achieve results 
(Parsons, et al., 2013). According to Parsons et al. (2013) these are tasks that are needed 
to implement and manage interventions, and the tasks to be executed require inputs to 
yield anticipated results. Generally, this variable is essential in detecting challenges 
during implementation as well as measuring programme coverage (Parsons et al., 2013). 
According to The Presidency (2007), efficiency indicators are used to measure how 
quickly inputs are translated into results, as they address the implementation stage of the 
intervention. In the context of this research, activities variables for the antiretroviral 
treatment intervention are adherence counselling, laboratory services and prescription of 
antiretroviral drugs. Government recommends that each individual undergo adherence 
counselling prior antiretroviral treatment. According to literature the most common 
measure for medication adherence is pill count (Lee, Kusek, Greene, Bernhard, Norris, 
Smith & Wilkening et al., 1996) among others. Patient‘s health outcomes are monitored 
frequently by testing for CD4 and viral load. CD4 is a measure of the strength of the 
immune system, while viral load is level of the HIV virus in the body. The two tests are 
measured using a laboratory value. The national treatment guideline recommends one 
pill fixed dose per day. Depending on the reaction towards treatment this might change 
to a combination of three different drugs. Data collected for this variable is sourced 
from medical records at the facility. 
2.5.3 The outputs 
This variable measures what needs to be produced by the intervention in order to be 
able to achieve the programme‘s outcomes (UNDP, 2011). Parsons et al. (2013) assumes 
that outputs are generally time-bound, similar to inputs and activities outputs are 
measured quantitatively. This variable can also be used to measure the efficiency of a 
program by describing the relationship of resources invested in a programme and the 
products. In practice when a programme fails to achieve its output there is high chance 
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of it being unsuccessful, however having achieved the outputs does not guarantee a 
successful program (DPME, 2011). The main output for the antiretroviral treatment 
intervention is the number of people initiated on antiretroviral treatment, number of 
viral load and CD4 tests performed, number of people who attended adherence 
counselling sessions, number of health workers trained on the national treatment 
guidelines and the antiretroviral treatment clinic stationery.  Data source for the output 
variables is sourced from medical records at the facility and district health information 
system. 
2.5.4 The outcomes 
The outcome variable measures short or medium term results. It focuses on immediate 
changes brought by the intervention (UNDP, 2011). Parsons et al. (2013) purport that 
an outcome is a consequence of a specific output. This variable is always aligned to the 
programme‘s objectives; it essentially measures what the programme achieves. 
According to literature, the primary outcomes of the antiretroviral treatment 
interventions are (a) retention in care (Doshi et al., 2014) (b) viral load suppression 
(Cescon et al., 2011; Fielding et al., 2008; Jobanputra et al., 2015; Nachega et al., 2009) and 
(c) mortality (Budgell et al., 2015; Wandeler et al., 2012). The dependent outcome 
variable for this research is viral load suppression, defined as viral load value below 50 
copies as per national guidelines. Data for the outcome variables is collected from 
medical records at the facility and district health information system and vital registers. 
Other explanatory variables are clinical characteristics comprised of baseline CD4, 
opportunistic infections, WHO clinical staging and treatment history; while 
demographic characters include age, sex, type of residency (township or village/farm). 
2.5.5 The impact 
The impact focuses on the vision or overall goal of the intervention (UNDP, 2011). It 
measures the ultimate benefits for the target population (UNDP, 2011). The Presidency 
(2007) states that impact is a result of achieving a specific outcome of the programme 
with the aim of changing a situation. Such change is likely to happen after a period of 
three to five years or even more depending on the type of an intervention. The impact 
variable measures the effectiveness of a programme, under the assumption that the 
achievement of inputs and outputs will translate into outcomes. It can be measured 
using both quantitative and qualitative methods. In the context of the antiretroviral 
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treatment intervention, the impact variables are life expectancy and HIV incidence. Life 
expectancy is defined as number of years alive while HIV incidence is new HIV 
infections. Data for the impact variable can be collected from surveys. 
Figure 5 illustrates variables used in monitoring and evaluation of the intervention of 
the antiretroviral treatment intervention. Each result level is aligned to a variable or 
indicator that will be used to collect information for that level. 
 
Figure 5: Variables or indicators used in monitoring and evaluation of the antiretroviral 
treatment intervention. 
2.6 Theoretical framework 
Interventions that are geared towards development are grounded on theory and 
evidence, and this is no different to HIV interventions. Many scholars have developed 
frameworks and theories that can be used to understand behavioural change in HIV 
interventions at individual, community or ecological level. These include Health belief 
model (Rosenstock, Strecher, & Becker, 1988), Theory of planned behaviour also called 
Theory of reasoned action (Fisbein & Ajzen, 1975), Stages of change model (Prochaska 
& Velicer, 1997), AIDS risk reduction model (Catania, Kegeles, & Coates, 1990), Social 
cognitive theory (Redding, Rossi, Rossi, Velicer, & Prochaska, 2000) and Empowerment 
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theory (Zimmerman, 2000). For evaluation of interventions the theory of change is used 
to explain the causal link from resources to results and can be explicitly tested (Funnell 
& Rogers, 2011). 
In HIV infected individuals, the antiretroviral treatment suppresses the virus; however 
this outcome is achieved only when the person living with HIV is at least 80 per cent 
adherent to treatment (McNabb, Ross, Abriola, Turley, Nightingale & Nicolau., 2001). 
Therefore, adherence plays a key role for people living with HIV to enable them to 
achieve viral load suppression and improve the quality of life.  As such, social and 
behavioural factors have an influence on adherence behaviour, consequently having an 
influence on health care utilisation and health outcomes of people living with HIV 
(Kagee, 2008). The WHO (2003) has determined three factors that are an impediment 
to optimal antiretroviral treatment adherence, namely, treatment characteristics, patient 
characteristics, and the relationship between the health professional and patient. To 
further understand the influence exerted by some of these variables towards the 
outcomes of the antiretroviral treatment intervention two social cognitive theories are 
reviewed to conceptualise the phenomenon of antiretroviral treatment adherence. In 
combination with the theory of change, results chain and framework the health belief 
model and theory of planned behaviour will be carried forward to explain findings of 
this study. In addition, the theory of gender and health will be used to explain 
differences in health practises and illness experiences amongst males and females. 
2.6.1 Health belief model 
Health Belief Model was first developed in the 1950s by Rosenstock et al. (1988) to 
address problem behaviours that evoke health concerns by exploring why people do not 
take preventative health measures. The model was based on them wanting to 
understand why free tuberculosis health screening programme was unsuccessful 
(Conner & Norman, 2005).  This model was conceptualised on the basis of six 
determinants or independent predictors of health behaviour. According to the model, 
an individual‘s (1) perceived susceptibility to a health condition and (2) gravity/severity 
(leaving disease untreated) of the disease influences individual‘s perceived risk of 
disease, (3) perceived benefits of avoiding risk and (4) perceived barriers associated with 
the condition influences perception of the worth of the health behaviour, (5) cues to 
action to activate a readiness to change and (5) confidence in the ability to take action 
(self-efficacy) influence perceived threat (Rosenstock et al., 1988). The model is more 
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advantageous in that it has successfully increased voluntary screening rates of various 
illnesses. It formed basis of various health behaviours and it does not have strict rules 
on variable combinations thus providing flexibility and adaptability to various health 
interventions (Orji, Vassileva, & Mandryk, 2012).   
As with other theories, the model is subjected to criticism. The model does not provide 
clear definitions of individual variables leading to the lack of rules for combination 
formulation of the perception variables and their relationships (Armitage & Conner, 
2000). Secondly, the model has a low predictive capability of determinants. Further 
weaknesses are its failure to include positive effects of health impairing behaviour 
patterns (e.g smoker may disregard health risks because they enjoy smoking) and social 
influence variables (Stroebe & de Wit, 1996). 
2.6.2 Theory of planned behaviour 
Theory of planned behaviour is a cognitive theory developed by Azjen (1988), which is 
an extension of theory of reasoned action developed by Fisbein & Ajzen (1975) by 
including measures of perceived behavioural control as determinants of intention and 
behaviour. It is concerned about factors that influence a person‘s decision to undertake 
a particular behaviour as long as that behaviour is intentional and this is explained by a 
causal chain that links attitudes, subjective norms, and perceived behavioural control to 
belief in a behaviour through behavioural intention (Brewer & Rimer, 2008). The causal 
chain is described using the following logic: behaviours are most likely to be influenced 
when individuals adopt positive attitudes about the behaviour; the behaviour is 
perceived positively by key people who influence the individual (subjective norm); and 
the individual has a sense that he or she can control the behaviour (perceived 
behavioural control) (Sutton, 1997). It posits intention as the most important 
determinant of behaviour (Fisbein & Ajzen, 1975). Intention is defined as a motivation 
required in performing certain behaviour (Armitage & Conner, 2000). Consequently, the 
more one intends to engage in this behaviour the more likely is its performance 
(Armitage & Conner, 2000).  
Armitage & Conner (2000) highlighted advantages and limitations of using this theory in 
public health interventions. Theory of planned behaviour can be used to explain why 
other people engage in particular health behaviour. It also takes into consideration other 
external factors and does not only focus on individual‘s beliefs. Its major weakness is 
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that it functions under the assumption that all behaviour is planned and controlled by 
the individual. Another weakness of theory of planned behaviour is that it does not take 
into consideration times when people may not be responsible for their behaviour. 
Figure 6 shows an integrative model of health belief model and theory of planned 
behaviour to show the relationship of health beliefs and behaviour variables that can 
influence optimal adherence. In this figure it can be seen that the adherence behaviour 
can be adopted if there is the intention to perform the behaviour, if the individual is 
equipped with the skills to perform the behaviour, and if there are no impediments to 
prevent behavioural performance there is chance that the adherence behaviour will be 
performed. Also, intention to perform the behaviour is underlined by having people that 
positively influence the individual, the right attitude and the confidence that he or she 
can perform the behaviour. All these variables are underpinned by the beliefs or 
perceptions on susceptibility, severity, risks, benefits, barriers and signs to act on an 
illness.  
 
Figure 6: Integrative model that depicts factors that influence optimal adherence 
behaviour. 
Adapted from Fishbein 2000, DeBruin et al., 2005, Munro et al., 2007 
2.6.3 Theory of gender and health 
This theory sought to explain disparities in health practices and illness experiences 
accounted for by gender (Courtenay, 2000). Connell purport that many cultures nurture 
masculinity in order to maintain the male power. Masculinity is accompanied by qualities 
of a ‗real man‘ —tough, fearless and physical strength. The theory posits that health 
related beliefs and behaviour are a means of demonstrating femininity and masculinity 
(Courtenay, 2000). It proposes that ―the social practices that undermine men‘s health 
are often signifiers of masculinity and instruments that men use in the negotiation of 
social power and status‖ (Courtenay, 2000, p.1385). In accordance to Connell & Connell 
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(2005), men often dismiss their health needs and engage in behavioural risks because 
they view themselves as a stronger sex. This allows men‘s perpetual use of unhealthy 
beliefs and behaviours that help them to sustain and reproduce social inequalities that, 
in turn highlight men‘s poor health habits. It is the pursuit to maintain this dominant 
status that puts men‘s health at risk. Literature suggests that health behaviours have 
been found to be key explanatory variables that highlight the differences in health status 
between men and women (Verde, Li, & George, 2003). 
2.6.4 The theory of change    
The theory of change is one form of theory-based evaluation where the causal link from 
resources to results can be explicitly tested (Pawson, 2003). Theory of change requires 
an explicit clear articulation of the road map of how the intended outcomes will be 
achieved (Weiss, 1995). A theory-driven evaluation narrates how, for whom, and under 
what assumptions do interventions produce or fail to produce results (Nakrošis, 2014). 
The theory of change emanates from the work done at Aspen Institute Roundtable 
(Fulbright-Anderson, Kubisch, & Connell, 1998) where it was aimed at planning 
community-based interventions.  A theory of change approach states that ―…activities 
A1, A2, and A3, if properly implemented (and with the ongoing presence of contextual 
factors X1, X2, and X3), should lead to outcomes O1, O2 and O3; and, if these 
activities, contextual supports (assumptions), and outcomes all occur more or less as 
expected, the outcomes will be attributable to the intervention‘‘ (J. P. Connell & 
Kubisch, 1998, p. 2).  
The key proponents of the theory of change Connell & Kubisch (1998) and  Mason & 
Barnes (2007) posit that the theory of change can enhance intervention planning, 
promote decisions focused on prioritisation of evaluation methods and questions, can 
prove that the evidence of change can be attributed to the intervention without using 
experimental studies in evaluation. Development of the theory of change requires 
stakeholder participation, whereby all relevant stakeholders must have their theories of 
what are the outcomes they anticipate to attain, how they wish to achieve them and why 
they should be delivered, not forgetting the context in which the programme operates 
(Connell and Kubisch, 1998). Despite the challenges experienced with the use of theory 
of change, it is still valued by many evaluators (Prinsen & Nijhof, 2015). One of the 
valued aspects is that it reflects more on the impact of an intervention on the outset. 
Consequently, interventions put more emphasis on the change rather than the 
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deliverables and outcomes. The second aspect is that it is concerned about a detailed 
pathway to change (Anderson, 2006). Another key principle of theory of change is the 
ability to implicitly state external factors, such as assumptions and risks that underpin 
programme processes (Weiss, 1997) in order to provide the credibility that observed 
changes are attributed to the intervention. The fourth and last valued principle is that 
the theory of change endeavors to assist understand and pin down the complexities of 
change processes in interventions (Prinsen & Nijhof, 2015).   
Some of the challenges identified regarding theory of change are starting to re-surface as 
more evaluators adopt this theory-derived evaluation approach. Firstly, Stufflebeam & 
Shinkfield (2007) noted that theory of change requires a lot of data and that it could 
hinder the development of a successful intervention. Secondly, Coryn, Noakes, Westine, 
& Schröter (2011) noted that there‘s arising confusion during evaluation, as to whether 
evaluation is conducted on the intervention itself or the theory underpinning the 
evaluation. When an intervention fails to achieve its intended outcomes is the problem 
centered on a weak theory of change or mismanagement of the intervention. The third 
activist argues that theories will not necessarily solve societal problems and elaborate 
why the intervention fail (Scriven, 1998). However, proponents such as Weiss (1997) 
advocate that black box evaluation, which is the measurement of outcomes without 
focusing on process of change from intervention inception to outcomes can still be 
done systematically. Despite, the theory of change being highly utilised in evaluations it 
has a shortfall in that it does not detail the methods to use in evaluation and how and 
who articulates it, hence there is wide variation in implementation of the theory of 
change (Mason & Barnes, 2007).   
In the context of the antiretroviral treatment intervention the theory of change for the 
intervention is to ‗provide universal access to antiretroviral treatment to improve 
survival rate and further reduction of HIV transmissions through viral load 
suppression‘. Drawing from the programme theory the following assumptions are 
described to sequentially link inputs, activities, outputs, outcomes and impact(s); 
o Linking HIV diagnosed individuals to care until such time of antiretroviral 
treatment initiation to achieve increased antiretroviral treatment coverage. 
o Individuals on antiretroviral treatment remain in care. 
o Optimal treatment adherence to achieve sustained viral load suppression and 
survival. 
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o Continued awareness of responsible sexual behaviour to reduce HIV 
transmissions. 
Figure 7 depicts the proposed theory of change for the intervention illustrating a 
sequence of events under predefined assumptions. The successes of this intervention 
are dependent on strengthened health systems that are easy to access, strong political 
will and stability to support HIV policies, clear policy and clinical guidelines, financial 
sustainability to support HIV care services, and lastly, HIV infected persons taking the 
responsibility to seek health together with awareness and understanding of the disease 
(self-efficacy). The relationship between Department of Health, facility staff, laboratory 
staff is critical to the change process; hence there is a need for close collaboration and 
good coordination to improve patient‘s health status. 
 
Figure 7: The proposed theory of change for the South African antiretroviral treatment 
intervention.    
2.6.5 The results chain and framework  
The results chain is a tool used to measure performance; it provides answers to two 
questions, whether the invested resources resulted in intended outputs and whether 
there is tangible progress on outcomes and impact (WHO, n.d).  According to 
Margoluis, Stem, Swaminathan, Brown, Johnson, Placci, Salafsky & Tilders (2013) a 
results chain represents an assumed causal relationship between impact and outcomes 
through invested resources. The results chain is developed in such a way that it 
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apprehends the essential elements of the logic model and the cause-effect relationship 
between inputs, activities, outputs, outcomes and impact. As indicated in the Section 
2.5.3, 2.5.4 and 2.5.5, outputs are services or immediate results provided by the 
programme, outcomes are the benefits of that service to the target population while 
impact is the change in behaviour as a consequence of the outcome to the target 
population.  
Figure 8 is a schematic representation of the results chain for the intervention. The 
figure highlights a causal link from the intervention‘s inputs to the impact. This study 
will put more emphasis on the outcomes. 
 
Figure 8: Results chain of the antiretroviral treatment intervention, depicting a link of 
inputs to outcomes. 
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2.7 Assessing outcomes of antiretroviral treatment intervention in 
Mankweng, a conceptual framework 
After introducing the research problem statement and the methodology, thereof, this 
paper began by reviewing literature that allows us to understand challenges of 
monitoring and evaluation systems. This section provides a road map on how research 
will be conducted post literature review. A conceptual framework is a summary of all 
the sections Chapter 1 and 2 discussed in the literature review.  
Figure 9 shows a summary of how the research question links in with the literature that 
trails its origin and the literature that is explicitly detailing the procedures of resolving 
the question. Our preliminary analysis (Section 2.2) and past evaluation studies (Section 
2.3) suggest that retention in care; viral load suppression and mortality are the outcome 
measures of the antiretroviral treatment intervention. However, so far, none of the 
studies have assessed antiretroviral treatment outcomes in rural parts of Limpopo 
Province. Further, previous studies have failed to explicitly explain their findings using a 
theoretical and/or explanatory framework. The theory of change and results chain will 
be used to interpret the findings.  
 
Figure 9: Diagram depicting the research problem, possible explanations and proposed 
methodology of pursuing the problem 
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At this point, the research has two research questions, (1) ―What is the proportion of 
adults with viral load suppression among people taking antiretroviral treatment for 12 
months?‖ We downplay the other two outcomes of the antiretroviral treatment 
interventions for two reasons. The literature has always reported evaluation on outputs 
of the intervention. However, it is over a decade since the introduction of antiretroviral 
treatment, by far it is evident that the intervention is efficient therefore it is now 
necessary to focus on the effectiveness of the intervention. Second, with the new 
UNAIDS targets that are aimed at ending the epidemic in 2030, it is imperative to start 
evaluating outcomes that will fast track the intervention to 2020 targets. Lastly, current 
focus must shift towards evaluations that measure tangible progress towards the impact.  
Another research question is ―What are the factors associated with failure to achieve 
viral load suppression among people on antiretroviral treatment for 12 months? The 
research opt to understand factors that may influence or lead to failure to achieve the 
intended outcome. 
Second, the research sought to provide insight on outcomes evaluation of the 
antiretroviral treatment intervention in rural parts of Limpopo, by conducting the study 
at the largest HIV treatment site that offers HIV care and treatment to dominantly rural 
residents of Mankweng. To understand factors that may influence failure to achieve the 
anticipated results will be probed using binomial regression model. The method has 
been previously used in studies that employed a cross-sectional design. The research 
uses the last value carried forward rule to avoid some limitations associated with missing 
data. 
The research is situated within the monitoring and evaluation field, which is a system 
used for managing and improving results. It provides sponsors and governments with 
information on progress towards achieving results thus providing evidence on what is 
working and what seem to not be working. The research will in particular focus on 
evaluation as it measures the effectiveness of the intervention. The main components of 
evaluation are formative, process, outcome and impact evaluation. This research will 
focus on outcomes evaluation as we are assessing the performance of the intervention. 
The outcome variable, viral load suppression is defined as virus level below 50, which 
will be sourced from laboratory results obtained for each individual.   
This research sought to propose the theory of change for the intervention to interpret 
evaluation findings. The theory assume viral load suppression will be achieved under the 
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assumption that people are adherent to treatment. Further, the thesis will evaluate the 
results using the results chain to explain the causal link from inputs to the intended 
outcome. The research will also apply the theories of behavioural planning and models 
of self-regulation to determine other factors that drives change.  
It is this systematic summary of and decision-making based on chapter 2 of a literature 
review that provides us with a conceptual framework for our research or evaluation. 
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3 RESEARCH TECHNIQUES, PROCEDURE AND 
METHODS 
This chapter sets out to discuss and commit to a research strategy, design, procedure and 
methods. First, Section 3.1 discusses different research strategies underpinned by the key 
paradigms that guide research. Drawing from the literature, this section commits to a research 
strategy that will inform the study further detailing the selected strategy with support from 
literature. Third, Section 3.2 provides a brief introduction to different research designs and the 
author selects a single research design that conforms to the research guided by current and past 
studies that have conducted similar research. Fourth, Section 3.3 shares key techniques and 
procedures that were applied to assess outcomes of the antiretroviral treatment programme, the 
data collection instrument, target population, sampling and ethical considerations. Sub-section 
3.3.1 and 3.3.2 details the preferred instrument used to collect data and further describes the 
target population and sampling procedures. Section 3.3.3 demonstrates whether the participants 
in this research were safeguarded.  This section also highlights data handling and analysis. Lastly, 
the chapter shares some reliability and validity measures as well as limitations of the research 
methods. 
3.1 Research strategy 
In research, a theory is always guided by a paradigm that further guides the researcher to 
the methods applied (Bryman, 2012). As defined by Bryman (2012, p. 35) a research 
strategy is ―a general orientation to the conduct of social research‖. Literature has 
strongly affirmed that the three research strategies are quantitative, qualitative and mixed 
methods (Bryman, 2012; Wagner, Kawulich, & Garner, 2012). This study used a 
quantitative research approach reason being that the author has formulated a theory 
guided by the literature. The data collected in a quantitative study will either support or 
disprove the theory (Creswell, 2013). To make it clear, Bryman (2012) explains that 
quantitative method is a measurement in the form of numbers during collection and 
analysis of data, it further determines a relationship between variables. Meanwhile, 
emphasis on large sample size is critical so the research can be able to make inferences 
to a large population size free of bias and sampling error (Wagner et al., 2012). The 
approach is highlighted in the studies that have investigated similar research questions as 
illustrated below.  
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A study by Fox, Shearer, Maskew, Fox, Shearer, Maskew, et al. (2012) antiretroviral treatment 
assessed antiretroviral treatment outcomes over a period of seven years at an urban clinic in 
South Africa. Primary outcomes were death and loss to follow up. Log binomial regression 
containing Poisson regression and robust error estimation were used to investigate predictors of 
death and loss to follow up. Summarily, 90 per cent of patients suppressed the virus, and 76 per 
cent were retained in care after a year on treatment. One-year mortality was below 11 per cent in 
all calendar years. After the first 12 months on treatment monthly rates of death and loss to 
follow up decreased significantly and remained unchanged. The authors estimated that 25 per 
cent of patients were lost to follow up and 16 per cent died after seven years on ART. Overall, 
more interventions are required to specifically address the issue of attrition.  
In rural areas of the Southern Africa a logistic regression model was used to determine factors 
associated with no loss to follow up after ART initiation, no returning to facility after the start 
of ART and further competing models were used to analyse loss to follow up and death. The 
analysis revealed high rates of mortality and loss to follow up. Young age and male gender were 
associated with the likelihood of no loss to follow up (Wandeler, Keiser, Pfeiffer, Pestilli, Fritz, 
Labhardt, Mbofana, Wandeler, Keiser, Pfeiffer, Pestilli, Fritz, Labhardt, Mbofana, et al., 2012).  
Another study by Doshi Doshi et al. (2014)sought to assess sought to assess proportion 
of clients at key stages of the HIV continuum of care and further examining factors 
associated with achieving retention in care and viral load suppression. Odds ratios and 
frequencies were calculated for outcome of each predictor variable. In year 2011, over 
500 000 clients sought health services at the insurance-funded facility in the USA. Of 
these, 62 per cent attended at least one medical visit. Of these, 82 per cent were retained 
in care, and 72 per cent achieved viral load suppression. Viral load suppression was 
higher among retained clients versus clients who were not retained. Low levels of 
retention and viral suppressions were among youth and young adults (13 - 34 years).  
Lastly,  in Canada a study was conducted to examine time to viral load suppression also 
the authors hypothesised that there was no association between socio-demographic 
factors, clinical factors and viral load suppression. The authors found that the median 
time to suppression was 4.55 months (Inter quartile range (IQR) 3.99 - 7.89 months). 
Multivariate analyses found that age, male sex, province ethnicity, history of injectable 
drug use, and baseline viral load were associated with viral load suppression (Cescon 
Cescon et al., 2011) .    
From the above discussion, it was noticeable that relationship between variables and 
testing of theories is the core of the quantitative strategy. This conforms to Bryman 
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(2012)‘s argument that quantitative strategy is able to reveal relationship between 
variables. This study will benefit from reporting proportions of patients who achieved 
viral load suppression.    
3.2 Research Design 
Literature defines a research design as a blueprint of any research project as it provides 
credibility, feasibility as well as the relevance of a research project (Babbie, 2015). There 
are five prominent research designs described in literature, namely, experimental, cross-
sectional, longitudinal, case study and comparative (Wagner et al., 2012).  
This research applied a cross-sectional design because data was collected simultaneously 
at a single time point (Wagner et al., 2012).  A cross-sectional design provides a snapshot 
of an occurrence as it happens, describing or comparing a variable to a particular 
standard therefore summarising the relationship between two or more variables 
(Bickman & Rog, 2008). However, the design has to be applied with caution as it cannot 
postulate cause-effect relationships (Bickman & Rog, 2008). Below is a review of studies 
that have applied a cross-sectional design to the studies that conducted research similar 
to this.  
Fatti, Grimwood, & Bock (2010) conducted a study to compare baseline characteristics 
and treatment outcomes between patients managed at different levels in the health 
system. Data was collected from medical records of patients who started treatment 
between December 2001 and December 2007 at 59 health facilities in both urban and 
rural areas of South Africa. Kaplan-Meier estimates, competing risks cox and logistic 
regression models revealed that attrition, retention and death were superior at primary 
health clinics (PHC) despite PHC patients having more advanced clinical stage diseases 
when starting ART. Fielding and colleagues (2008) sought to determine risk factors 
associated to suboptimal viral load suppression by extracting data from an electronic 
database of HIV-infected patients receiving ART from 1 July 2004 to 31 March 2005 in 
a workplace-based HIV care programme in South Africa. A multivariate analysis 
revealed that a ten times decrease in viral load was a strongest predictor for viral load 
suppression at 12 months, while high baseline viral load and advanced HIV progression 
were risk factors for suboptimal viral load suppression. Another study by Budgell et al. 
(2015) that compared mortality in patients who were in care and those lost after 
treatment initiation. Data was prospectively collected among HIV-infected patients 
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enrolled for antiretroviral treatment between April 2004 and May 2012. The primary 
outcome variable was death either in care or lost to follow up. The cox proportional 
hazard models revealed that 14.6 per cent of patients who have died and being lost 
accounted for a minority of deaths across multiple stages of loss to follow up. Although, 
mortality rates in patients lost to follow up were superior to patients in care, most ART-
associated deaths occurred while on treatment.  
The articles clearly demonstrated different outcomes that occurred during a specified 
period of time among patients receiving antiretroviral treatment, thus providing a 
snapshot of outcomes during that time interval. It is clear that time interval can range 
from 12 months and above, however there is no standard time interval to use during 
research. Notably, the articles determined relationship between variables.  The study 
aims to follow a similar approach but focusing on outcomes achieved after a year of 
antiretroviral treatment initiation the study will also benefit from being able to 
determine factors associated with failure to determine viral load suppression. Therefore, 
this study falls within the research design norms.  
3.3 Research procedure and methods 
This section sought to provide detailed specifications on how the research was 
conducted, detailing the type of instrument used to collect data, the target population 
that was studied and the sampling techniques used further demonstrating the ethical 
considerations applied when conducting this research. The section further zooms onto 
aspects of data collection, storage and analysis.  
3.3.1 Data collection instrument 
Alongside with choosing the type of design, the researcher explores potential tools for 
data collection (Bickman & Rog, 2008). There is common understanding among 
scholars that a data collection instrument is utilised to gather information from a studied 
population in order to answer a specific research question and draw conclusions 
(Bickman & Rog, 2008). In research, the sources of data usually informs the type of 
instrument to use for data collection, virtually instruments are designed and 
implemented to collect what needs to be known (Wagner et al., 2012). The two 
fundamental instruments for data collection are structured and unstructured interview 
schedules (Wagner et al., 2012; Gill, Stewart, Treasure, & Chadwick, 2008). A structured 
interview is often referred to as a questionnaire (Gill et al., 2008).  
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For this research a questionnaire was used to gather data originating from patient 
medical records without interacting with the participants. In accordance to Gill et al. 
(2008), a questionnaire is comprised of a pre-determined list of questions in a closed-
ended format —where there is no opportunity for follow up to responses that requires 
further elaboration. It is often a preferred tool to use in survey research, field research, 
experiments and other forms of observation (Babbie, 2015). The variables listed on the 
questionnaire in order to collect data were in alignment with the clinical stationery used 
at South Africa‘s antiretroviral treatment facilities. The questionnaire measured five 
components: (1) Patient profile or demographics, (2) clinical characteristics, (3) 
treatment history, (4) viral load monitoring, and (5) adherence characteristics. In total 
there were 23 variables on the questionnaire.  
We reviewed previous studies that have used similar data collection instrument in their 
research. Cescon et al. (2011) used a fully structured questionnaire often referred to as 
data abstraction form to extract data at data centres of the participating cohort sites to 
probe time to viral load suppression and factors associated with viral load suppression 
among a national cohort of persons on antiretroviral treatment in Canada. The study 
found that the median time to suppression was 4.55 months (IQR 3.99 - 7.89 months) 
while older age, male sex, treatment in Ontario rather than British Columbia, non-
injectable drug users history, and having an AIDS diagnosis at baseline were likely to 
achieve viral load suppression. Another retrospective cross-sectional study by Saka et al. 
(2014) sought to determine factors associated with loss to follow up was conducted in 
Togo. Data was abstracted from medical records of HIV-infected individuals on 
antiretroviral treatment who were lost to follow up between January 2008 and October 
2011. The multivariate analysis revealed factors associated with early loss to follow up 
and confirmed high mortality in these patients. Predictors of early loss to follow up were 
ages below 35 years, presence of opportunistic infections at the start of antiretroviral 
treatment, living in rural area and receiving HIV treatment at public health system.  
The articles above show that a questionnaire is an appropriate instrument used to 
abstract data from databases or patient medical records in order to assess outcomes of 
the antiretroviral treatment intervention in both developed and developing countries. 
Although, one article extracted data on different outcomes there were still 
commonalities within the questionnaires including patient demographics and clinical 
characteristics. This study will accrue benefits of being able to extract data on 
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demographics, clinical information including adherence characteristics. This study 
conforms to norms of developing a questionnaire that is used for transferring 
information from medical records.  
3.3.2 Target population and sampling 
A target population for a study is ―that group (usually of people) that participate in 
research who we want to draw conclusions‖ (Babbie, 2015, p. 116). The study 
population for this research is HIV-infected adults whom are on antiretroviral treatment 
for 12 months attending primary healthcare clinic, Phela-O-Phedise, at Mankweng from 
01 January 2013 to 31 December 2014. The participants include adults of 18 years and 
above. To evaluate the viral load outcomes at 12 months, patients that were lost to 
follow-up, died, or transferred out to other facilities were excluded from the study. A 
threshold of 12 months on treatment was selected because previous studies have proven 
that it takes close to six months for HIV viral load to diminish to below undetectable 
levels (Mellors, Margolick, Phair, Rinaldo, Detels, Jacobson & Muñoz, 2007). 
Table 1: Sample size estimation for the assessment of outcomes of the 
antiretroviral intervention programme in Mankweng.  
Viral load 
suppression level 
Confidence 
interval  
Estimated 
Sample Size 
Number needed to screen 
(adjusted for 10% loss rate) 
60% 90% 369 406 
75% 90% 288 317 
90% 90% 138 152 
 
3.3.3 Ethical considerations when collecting data 
Ethical research is conducted with the aim to protect the research participants. In 
accordance to Wagner et al. (2012), when conducting research the following ethical 
considerations must be applied. Firstly, gatekeepers grant permission to conduct a study. 
Secondly, it is the responsibility of the researcher to ensure that participants are not 
subjected to any type of harm when participating in the research. Reciprocity means 
giving back something to those who have provided data, such as sharing research 
results. Deception happens when the participants are intentionally led to have false 
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beliefs. Informed consent is ―an individual‘s personal right to agree to participate in a 
research study after fully understanding the total research process and consequences‖ 
(Wagner et al., 2012, p. 68). An informed statement should explicitly clarify the research 
to be conducted (Bickman & Rog, 2008). Lastly, anonymity and confidentiality refer to 
safeguarding of the identity of the participants (Wagner et al., 2012). Anonymity means 
the researcher does not have evidence on the identity of the participant while 
confidentiality means that the researcher knows the identity of the participant but keeps 
it a secret (Wagner et al., 2012). The paragraph below is the researcher‘s biosketch 
declaring interest in the research.   
I, Ramatsobane Johanna Ledwaba a Master of Management (specialising in Monitoring 
and Evaluation) student from University of the Witwatersrand, School of Governance 
am conducting this research as a partial fulfilment for my degree. The key gatekeepers 
have granted permission to conduct this study. Ethical clearance was obtained from 
University of the Witwatersrand Human Ethics Research Committee. Permission to 
conduct the study was granted by the Limpopo Provincial Department of Health and 
Mankweng hospital Chief Executive Officer (CEO). The study was not sponsored by 
any organisation. The research did not bring harm to any human being as information 
was transferred to the questionnaire without talking to patients. A unique patient 
identifier was allocated to each patient‘s information; therefore patient names remained 
anonymous and confidential. Research report will be submitted to the Department of 
Health to serve as a resource.  
3.3.4 Data collection and storage 
The study was conducted by reviewing medical records of adults receiving antiretroviral 
treatment at Mankweng Hospital using a customised questionnaire (data abstraction 
form). After obtaining ethical clearance from University of the Witwatersrand and 
permission from Limpopo provincial Department of Health the researcher sought 
permission to conduct the study from the hospital CEO. After the permission was 
granted, the researcher made an appointment with the facility manager to discuss the 
processes to be undertaken during the period of data collection. The facility manager 
with the help of the administrator clerk and data capturer provided a sampling frame 
containing a list of all patients who initiated treatment between 01 January 2013 and 31 
December 2014. Eligible participants, those who were 18 years and older and remained 
in care after 12 months on treatment were computer randomised in Microsoft Excel 
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using unique patient identifiers. The researcher employed a questionnaire to abstract 
information for each patient. Collected data was entered into Microsoft excel 
spreadsheet, duplicated and stored on two password protected cloud drives (Google 
drive and Dropbox) and a computer. Completed questionnaires were stored in a locked 
cabinet. 
3.3.5 Data processing and analysis 
Data from the questionnaire was entered into excel, but prior to data entry text 
responses were number coded. When coding the responses, the researcher started with 
a small number (e.g 0) and missing data was represented with a period. The unique 
patient identifier for each patient medical record was entered vertically while the 
measured variables were entered horizontally. All the entered data was duplicated to 
create a backup copy of the file.  
After data entry, data was cleaned to ensure accuracy. Each questionnaire was 
crosschecked for data entered into the database. Frequencies for variables were ran to 
identify errors that were committed during data capturing. Univariate analysis and 
binomial logistic regression were used to investigate association between variables. 
Bryman (2012, p. 713,717) defines univariate analysis as an ―analysis of single variable at 
a time, [while] multivariate analysis is an examination of relationships between three or 
more variables‖. In this study, binomial logistic regression analysis was done to identify 
factors associated with failure to achieve viral load suppression (detectable viral load). 
Frequencies and proportions were calculated to describe study participants in relation to 
key variables. Chi-Squared test and Fisher Exact test (if an expected cell value was less 
than 5) were employed to compare categorical variables between participants who 
obtained viral load suppression to those who did not. Continuous variables were 
compared using Mann-Whitney test. A confidence level of 0.05 was considered 
significant in all tests. During data analysis, any missing data was controlled carrying 
forward values (Sterne et al., 2009). All the analysis was conducted in IBM SPSS 
Statistics software, version 19 (SPSS Inc., an IBM company, Chicago, Illinois, United 
States). Here we reviewed previous studies that have used this type of data analysis to 
answer similar research questions.  
A study by Fielding and colleagues (2008) that sought to assess risk factors for sub-
optimal viral load suppression at 12 months among HIV-infected adults receiving ART 
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in a workplace-based HIV care programme in South Africa using logistic regression 
model. The analysis revealed that close to three-quarters of patients achieved viral load 
suppression (<400 copies/ml) at 12 months. A multivariate analysis demonstrated that 
ten times decrease in viral load at six weeks was the strongest predictor for sub-optimal 
viral load suppression at 12 months. In addition, site of treatment delivery had a 
significant influence on viral load outcomes. High baseline viral load and advanced HIV 
progression were risk factors for suboptimal viral load suppression at 12 months. In 
conclusion, the above findings suggest further probing on factors influencing outcomes 
at health facilities to guide development of effective ART programmes. 
 Also, Wandeler et al. (2012) employed logistic regression model to determine factors 
associated with no loss to follow up after ART initiation, no returning to facility after 
the start of ART. The analysis revealed high rates of mortality in patients who were lost 
to follow up after ART enrolment. Young age and male gender were associated with the 
likelihood of no loss to follow up. Similarly, a study conducted by Saka et al. (2014) 
sought to determine factors associated with loss to follow up implemented multivariate 
logistic regression analysis to determine risk factors for outcome loss to follow up or 
not lost to follow up. The multivariate analysis revealed key factors associated with early 
loss to follow up and high mortality in these patients. Predictors of early loss to follow 
up were age below 35 years, presence of opportunistic infections at the start of 
antiretroviral treatment, living in rural area and receiving HIV treatment at public health 
system. 
 The articles utilised logistic regression analysis to determine factors and predictors of 
outcomes of the antiretroviral treatment programme. Quantitative studies use bivariate 
and binomial logistic regression analysis in cross-sectional studies to assess the 
relationship between viral load suppression and other co-variables (demographics, 
clinical characteristics or adherence). Above studies have used binomial regression with 
Poisson when the risk outcome is above 20% this conforms to the norms of regression 
analysis. Taking these into consideration, this study will accrue benefits by being able to 
apply the binomial regression model with Poisson regression to address the following 
research question: what are the factors associated with failure to achieve viral load 
suppression?    
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3.3.6 Description of the respondents 
Data was abstracted from patient medical records to the questionnaire; this was done 
without talking to patients. Respondents were HIV-infected adults who are on 
antiretroviral treatment for twelve months. There were a total of 415 respondents, of 
which 284 were females and 131 were males. The respondents were between 18 and 70 
years of age, the majority (84%) were amongst the age group 34 – 41 years. Hundred 
and seventy-eight were residing in a rural informal settlement (village or farm) and 161 
were living in a rural formal settlement (township).  
3.4 Research reliability and validity measures 
Validity and reliability are key characteristics of an instrument as they are very critical in 
judging accuracy and meaning of the results (Bryman, 2012). Therefore it is necessary to 
evaluate the reliability and validity of the instruments during study design. The concept 
of validity refers to a judgement on how well it measures what it intended to measure 
(Bryman, 2012). To ensure face validity for the questionnaire used in this research was 
piloted to experts in the field to check it measures what it should measure. In research, 
external validity refers to the extent to which study findings can be inferred or 
generalised to a larger population (Bryman, 2012).  Bryman (2012) points out that in 
cross-sectional designs external validity is strong if population sampling is randomly 
selected. On that note, this research employed random sampling method to sample 
respondents from a larger population.  
The reliability of an instrument reflects its stability and the degree of consistency among 
questions (Kimberlin & Winterstein, 2008). Research reliability measures refers to the 
ability to repeat study findings (Bryman, 2012). Literature states the three types of 
reliability: stability, internal consistency and equivalence (Kimberlin & Winterstein, 
2008). Stability tests the reliability of a questionnaire if it used consecutively twice or 
more. It uses test-retest (intra-rater test) method to test reliability. Internal consistency 
measures interrelatedness among items by using Cronbach alpha coefficient. 
Equivalence is when two or more observers study a single phenomenon at the same 
time. Inter-rater reliability is measured on information collected by different observers. 
The inter-rater reliability is commonly used to estimate reliability when data is abstracted 
from medical files (Allison, Wall, Spettell, Calhoun, Fargason, Kobylinski & Farmer et 
al., 2000). Rather, the research performed test-retest method on 10 randomly selected 
medical records twice and utilising Cohen Kappa for nominal and interval (age, CD4, 
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viral load) variables (McHugh, 2012). According Landis & Koch (1977) the minimum 
acceptable coefficient is 0.6.  Cohen Kappa co-efficient(s) for the variables assessed 
were age, =0.65; CD4, =1; clinical stage, =1; baseline ART, =1; viral load =0.66; 
adherence counselling (undetermined, all values were constant) and type of adherence 
support, =0.60. Overall, all the tested variables obtained an excellent agreement.  
3.5 Research limitations 
This study has the following methodological limitations. First, the ART facility was 
purposively selected; therefore, it may not represent other treatment sites in Limpopo 
province. Second, due to time constrains evaluation was only conducted at one facility. 
Therefore, the study findings may not be generalised to all settings but only limited to 
the population at the facility. Third, the study collected data by transferring information 
from medical records to a questionnaire; this procedure has inherent limitations of data 
incompleteness as observed by missing data for some variables. The missing data have 
affected the statistical power of the study resulting in a larger p-value. However, 95 per 
cent confidence intervals were also reported. Fourth, the cross-sectional design was 
selected for collecting data for this study. However, this design prohibits definitive 
statements regarding the direction of associations among study variables. Lastly, the 
study lacks ecological validity because it uses a questionnaire that does not capture the 
daily life conditions of the studied participants. 
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4 PRESENTATION OF RESEARCH FINDINGS 
The primary objective of this study is to determine proportion of HIV infected adults 
who achieved viral load suppression in the first year of antiretroviral treatment. The 
second objective is to determine factors associated with failure to achieve viral load 
suppression.  The research found that so far no literature is available that report viral 
load outcomes in Limpopo Province. Therefore, this chapter is set out to present and 
discuss findings to the first research question (Section 4.1) — what is the proportion of 
adults with viral load suppression among people taking antiretroviral treatment for 12 
months? This discussion is accompanied by its hypothesis; there are high proportions of 
adults with viral load suppression among people taking antiretroviral treatment for 12 
month. Section 4.2 sought to share and discuss findings to the second research question 
— what are the factors associated with failure to achieve viral load suppression among 
people on antiretroviral treatment for 12 months? This section further discusses the 
hypothesis that states that multiple factors are associated with failure to achieve viral 
load suppression. Lastly, Section 4.3 provides conclusions to the answers for research 
questions one and two. 
4.1 Proportions of adults with viral load suppression among 
people who have been taking antiretroviral treatment for 12 months 
 
Table 2 describes baseline characteristics of people who achieved viral load suppression 
and those who did not achieve viral load suppression most importantly highlighting the 
differences and associations between the two groups.  
The goal of the antiretroviral treatment is to achieve viral load suppression, which is 
defined as a threshold where virus levels remain undetectable (Gagnon & Guta, 2014). 
This outcome was realised in 78 per cent of the people who were taking antiretroviral 
treatment for 12 months, while 22 per cent failed to achieve viral load suppression. The 
78 per cent suppression rate was comparable to another study conducted in rural 
settings of KwaZulu-Natal (Mutevedzi et al., 2010). A study that was conducted in 
Canada using a similar viral load threshold reported better outcomes (86%) (Cescon et 
al., 2011). Another study conducted in South Africa reported 71.5 per cent suppression 
using a higher viral load cut-off below 400 copies per ml at 12 months. A strict cut-off 
(< 50 copies per ml) was used for this research to be able to identify flaws within the 
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programme. However, this also makes it challenging to make comparison to other programmes 
that selected a different threshold.  
Among the people who visited the primary health clinic, Phela-o-Phedise, between 
January 2013 and December 2014 majority were females (67%) and 69 per cent of the 
people were in the primary stage of the disease (WHO clinical stage 1&II) while 31 per 
cent had advanced disease progression (WHO clinical stage III&IV). This trend is 
consistent to a study conducted in Togo on people who started treatment between 2008 
and 2011 (Saka et al., 2014). However, this was different to studies conducted before 
2010 in Southern Africa and Vietnam, in which the majority of people who visited the 
health facility for the first time were at the advanced stage of HIV (Fatti et al., 2010; 
Fielding et al., 2008; Nglazi et al., 2011; Nguyen et al., 2013; Wandeler et al., 2012). This 
finding suggests that in the last decade people sought HIV care and treatment when 
they were in their advanced stages of the disease. However, recent studies show a 
change in trend in this group of people.  
Table 2: Proportions of baseline characteristics in total and stratified by viral 
load suppression status 
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People who sought care and treatment during that period majority (91%) were sick as 
they started treatment with a CD4 count (a measure of immune system) below 350. 
These findings were also seen in similar studies conducted in the Sub-Saharan Africa 
(Fox et al., 2012; Saka et al., 2014). People living with HIV often get infected with 
Tuberculosis (TB) because they have a weakened immune system (Nglazi et al., 2011). 
In this study few individuals (15%) were co-infected with TB, of these 87% were on 
treatment and 13 per cent completed treatment, this is in line with South African 
treatment guidelines that recommend early initiation of TB treatment in people co-
infected with TB. In 2013, patients with CD4 below 350 were initiated on either 1-pill a 
day treatment or 3-pills a day treatment (SA treatment guidelines, 2013). Here, a large 
proportion (97%) of the people were prescribed 1-pill a day treatment. The 1-pill per 
day prescription was effected to reduce pill burden in patients taking long-term 
treatment leading to improved adherence to long-term treatment, as reported in other 
studies (Chesney, 2000; Sax, Meyers, Mugavero, & Davis, 2012). In accordance to South 
African treatment guidelines, almost everyone (99%) received pre-ART adherence 
counselling. Although it was shown that adherence support structures improve 
treatment efficacy (Wilkinson, 2013), close to half (46%) of the people did not have any 
form of support structure either at home or in the community while the remaining 
individuals (54%) had a treatment buddy. 
Twenty-two per cent of the people who were prescribed one pill a day failed to achieve 
viral load suppression compared to those who were on 3-pills a day treatment (9%). A 
quarter of people (24%) who were at the primary stage of the disease failed to achieve 
viral load suppression at 12 months. This was similar to a study conducted in South 
Africa (Fielding et al., 2008) and Swaziland (Jobanputra et al., 2015). In addition, 21 per 
cent of them had a CD4 count below 350. This is comparable to findings by Jobanputra 
et al. (2015).  Among the people who were co-infected with TB, 16 per cent failed to 
achieve viral suppression compared to 84 per cent that achieved viral load suppression. 
Although there were noticeable differences in baseline characteristics of people who 
achieved viral load suppression and those who did not, the difference was not 
significant.  Overall, there was no significant difference according to gender, age, locality 
type (p=0.660), baseline CD4 count (p=0.081), WHO clinical stage (p=0.397), TB 
infection status (p=0.284), opportunistic infections (p=0.443), baseline antiretroviral 
treatment (p=0.915), and type of adherence support (p=0.355), except for prior 
antiretroviral treatment adherence counselling (p=0.001) among people who achieved 
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viral load suppression and those that did not achieve viral load suppression. The 
findings show that there was evidence of high proportions of people who achieved viral 
load suppression among the people who were taking antiretroviral treatment for 12 
months.   
Although this is beyond the scope of the study, of 1 061 people who initiated 
antiretroviral treatment 64 per cent remained in care 12 months after ART initiation, 
compared to the proportion of patients who were lost to follow up (25%), transferred 
out (9%) and died (1%). 
 
4.2 Factors associated with failure to achieve viral load 
suppression among people on antiretroviral treatment for 12 months 
This programmatic evaluation of outcomes of the antiretroviral treatment intervention 
has identified factors associated with failure to achieve viral load suppression among 
people on antiretroviral treatment for 12 months. Table 3 shows risk factors associated 
with failure to achieve viral load. Risk factors were made up of demographics, clinical 
and treatment characteristics as well as adherence characteristics. Although the majority 
of the people were females, the male sex was more likely to fail to achieve viral load 
suppression (RR: 1.21; 95% CI: 0.68 – 2.14), this is in contrast with an evaluation study 
conducted in Canada and Asia that have shown that females were at risk of failing to 
achieve viral load suppression (Cescon et al., 2011; Huang et al., 2015; Syed et al., 2015). 
Though, the dissimilarity may be due to differences in population characteristics the 
research still highlights the need of interventions that will engage males from our study 
into HIV care and treatment early. 
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Table 3: Risk factors associated with failure to achieve viral load suppression 
 
 
People who were living in a village, farm or a township were not associated with failure 
to attain viral suppression (RR: 1.06; 95% CI: 0.62 – 1.81). Several previous studies have 
found no significant difference in viral load suppression between people living in rural 
and urban areas of South Carolina in USA (Weissman et al., 2015) and KwaZulu-Natal 
(Mutevedzi et al., 2010). People who were in the primary stage of the disease showed a 
trend towards failure to achieve viral load suppression (RR: 1.48, 95% CI: 0.75 – 2.91). 
On contrary, people who have reached the advanced stage of the disease were less likely 
fail to achieve viral load suppression (RR: 0.69; 95% CI: 0.15 – 2.85). This differs to 
other studies that have shown that people in the advanced stage of the disease were 
more likely fail to achieve viral load suppression (Fielding et al., 2008; Jobanputra et al., 
2015; Nglazi et al., 2011). People who have failed to achieve viral load suppression 
tended to have advanced immune suppression (CD4 below 350) (RR: 2.09; 95% CI: 
0.71 – 6.14, p=0.178), although this was not statistically significant. This is consistent 
with other studies conducted in South Africa and Swaziland (Jobanputra et al., 2015; 
Nglazi et al., 2011). Also, a large randomised controlled trial have proven that people 
who initiate treatment when they are ill (CD4 count below 350) have a higher risk of 
developing serious illnesses even death (Lundgren et al., 2015).  
TB co-infection decreased the risk of failing to achieve viral load suppression (RR: 0.83: 
95% CI: 0.37 – 1.85), while people with opportunistic illnesses showed a trend towards 
failing to achieve viral load suppression (RR: 1.48; 95% CI: 0.74 – 2.96). This was 
different to what was observed in Swaziland, where the opposite what was reported 
(Jobanputra et al., 2015).  In this study, people who were prescribed three-pill per day 
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treatment were more likely to fail to achieve viral load suppression (RR: 1.43; 95% CI: 
0.77 – 2.64). This is consistent to a study by Cescon et al. (2011) that showed that 
combination ART (3-pill treatment) showed a trend towards failure to achieve viral load 
suppression. Selection of baseline antiretroviral treatment is important to treatment 
adherence. Hence, government is switching three-pill regimen with a 1-pill fixed dose 
single tablet. Also, people who did not have social support had a risk of failing to 
achieve to viral load suppression this is consistent with a previous study from Kwazulu-
Natal that showed that adherence support structures improved viral load suppression 
(Wilkinson, 2013). Although these factors showed a trend towards failure to achieve 
viral load suppression, the estimates were not statistically significant. 
4.3 Conclusion 
Among the people on antiretroviral treatment at Phela-O-Phedise facility in Mankweng, 
78 per cent suppressed viral load at 12 month following the start of antiretroviral 
treatment, while 22 per cent failed to achieve viral load suppression. The majority of 
people who visited the facility during that time were females and 69 per cent were in the 
primary stage of the disease, while 31% were in the advanced stage of the HIV disease 
(AIDS). The males had an increased probability of failing to achieve viral load 
suppression. Most notably, the majority of the people were sick (CD4 count below 350) 
and were most likely fail to suppress viral load. On the contrary, people who were on 
the advanced stage of HIV had less probability of failing to suppress viral load. There 
was no association between type of residence and viral load suppression. However, 
people who were co-infected with TB have a less likelihood of failing to suppress viral 
load, mainly because most of them received TB treatment. On the contrary, patients 
who had opportunistic infections, prescribed 3-pill containing treatment and did not 
have any form of treatment support were more likely to fail to achieve viral load 
suppression.  
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5 DISCUSSION OF RESULTS 
This chapter exhibits interpretation of the research findings on the basis of a theoretical 
framework that has been outlined in Section 2.6. The interpretation is divided into two 
sections; the first one aims to interpret findings from the first research question— 
proportions of adults with viral load suppression among people who have been taking 
antiretroviral treatment for 12 months and the second part is focused on the second 
research question, factors associated with failure to achieve viral load suppression 
among people on antiretroviral treatment for 12 months. The interpretation of findings 
is performed by first the outlining the theory that will be used to interpret the findings 
followed by the findings then the implications. 
5.1 Proportions of adults with viral load suppression among 
people who have been taking antiretroviral treatment for 12 months 
As it was indicated in Section 4.1, there was evidence of viral load suppression in people 
who were on antiretroviral treatment for 12 months at Mankweng, although almost a 
quarter of them did not achieve the intended outcome. The outcome is driven by the 
theory of change that underpins the intervention. According to the theory of change 
―…activities A1, A2, and A3, if properly implemented (and with the ongoing presence 
of contextual factors X1, X2, and X3), should lead to outcomes O1, O2 and O3; and, if 
these activities, contextual supports, and outcomes all occur more or less as expected, 
the outcomes will be attributable to the intervention‘‘ (Connell & Kubisch, 1998, p. 2). 
In addition, the results chain is a tool used to measure performance as it provides 
answers to two questions; whether the invested resources resulted in intended outputs 
and whether there is tangible progress on outcomes and impact (WHO, n.d).  
Under the assumption that treatment adherence was mentioned the intervention was 
able to produce the intended outcome (viral load suppression) at 78 per cent. However, 
the intervention‘s effectiveness was not 100 per cent, suggesting that the assumption 
was violated in some individuals. How the people achieved viral load suppression is 
explained the results chain. The activities that led to the outcome for this intervention—
adherence counselling, laboratory services (CD4 count and viral load tests), and 
prescription of antiretroviral drugs were performed as indicated on Table 2. This finding 
implies that implementation of the intervention was efficient and it led to good 
outcomes. The turnout of events on the results chain shows that the chain was not 
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broken. As a result, all the assumed inputs, performed activities, and outputs have 
resulted in the intended outcome of viral load suppression; however this was not true 
for everyone who was sampled. This suggests the assumption did not hold for everyone. 
Regrettably, adherence levels were not measured hence we cannot say to what extent the 
assumption was violated. Because outcomes are markers of the success of the 
intervention, and 78 per cent was achieved the intervention was sub-optimally 
successful in this setting. 
5.2 Factors associated with failure to achieve viral load 
suppression among people on antiretroviral treatment for 12 months 
This section exhibits interpretation of the research findings that relate to the factors that 
have an influence on viral load suppression. The factors discussed in this section include 
patient characteristics, clinical characteristics and adherence characteristics.  
The theory of gender and health hypothesise that the quest for men to sustain 
authoritative status puts their health at risk (Connell & Connell, 2005). This is consistent 
with literature that reports that the cultural nurturing of male masculinity tends to deter 
men from attending health facilities (Verde et al., 2003) and this phenomena makes them 
vulnerable to HIV. The findings from this research revealed that majority of females 
visited the facility compared to males. Most importantly males were more likely to have 
detectable viral load compared to females. Therefore, it is possible that this pursuit for 
men to maintain and show ‗real man‘ characteristics deter them from visiting the facility 
but they only visit a health facility when they are too sick and that leave them at risk of 
failure to suppress viral load. As alluded by the health belief model that a person's belief 
in a personal risk of an illness together with a person's belief in the performance of the 
health behaviour predict the likelihood that the person will adopt the behaviour 
(Rosenstock et al., 1988). The vulnerability to HIV in men could be driven by the lack of 
belief in personal threat to HIV and lack of perception of the severity of the illness. The 
implication of this finding is that efforts need to be made to encourage and engage 
males into HIV care and treatment.   
The study also shows that a low baseline CD4 count (below 350) is a risk factor for 
failure to achieve viral load suppression after 12 months of antiretroviral treatment 
initiation. Generally, people with a low CD4 count are very sick and that means that this 
group of people sought HIV care and treatment late. The health belief model suggest 
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that a person's belief in a personal risk of an illness together with a person's belief in the 
performance of the health behaviour predict the likelihood that the person will adopt 
the behaviour (Rosenstock et al., 1988). According to the model, this group of 
individuals lacked the perception on the risk of HIV, which influenced their perception 
gravity of the disease when they left the disease untreated on hence they did not adopt 
the behaviour of seeking care early. This finding implies that there is a need for scale up 
of early HIV diagnosis that will lead to early treatment, thus making sure that the 
antiretroviral treatment intervention reaches all the people that need it.   
As shown in Section 4.2, people who visited the facility in the early stages of illness 
(clinical stage I&II) were more likely to fail to suppress viral load. The theory of planned 
behaviour suggest that behaviours are most likely to be influenced when individuals 
have positive attitudes about the behaviour; the behaviour is viewed positively by key 
people who influence the individual (subjective norm); and the individual has a sense 
that individuals can control the behaviour (perceived behavioural control) (Sutton, 
1997).  This group of patients still feels well because at this stage of the disease they do 
not show any symptoms of the disease, therefore it is hypothesised that after 12 months 
of treatment they would fair better than those who are at the advanced stages of the 
disease.  However, this was not the case in this study. Based on the model this group 
seems to lack the right attitude that adherence result in better health leading to failure to 
adopt adherence behaviour. This finding implies that this group of people requires 
intensified adherence counselling during antiretroviral treatment. Table 2 indicated that 
people who received three pill containing treatment and those who lacked social 
support were more likely to fail to suppress viral load. According to the theory of 
planned behaviour the lack of subjective norm or motivation is highlighted in people 
who did not have people (treatment buddies or family) whom they know that they belief 
they always take treatment accurately, hence they lost the intention to adhere to 
treatment. This implies that the individuals need motivation to comply to treatment 
correctly this can be done through intensified adherence counselling.   
Based on the theory of planned behaviour, prescription of three-pill containing 
treatment and occurrence of opportunistic infections were barriers to adoption of the 
adherence behaviour. This group experienced difficulty in taking treatment because of 
the 3-pill burden and being too ill from other illnesses hence they did not adopt 
treatment adherence behaviour. The national treatment guidelines recommend a one pill 
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fixed dose and preventative treatment for other illnesses. Therefore, this finding implies 
that there is a need for continued training of health care professionals to improve 
adherence to the guidelines.  
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6 SUMMARY, CONCLUSIONS, AND 
RECOMMENDATIONS 
This chapter encapsulates the research taking into consideration the findings and the 
conclusion that reaffirms the purpose of the study. It further shares the 
recommendations with respect to the overall study.  
6.1 Summary 
The study is set to assess outcomes of the antiretroviral treatment intervention in 
Mankweng. HIV viral load suppression is a key outcome indicator for intervention 
performance and in the context of public health concerns, it provides an insight into 
viral load suppression rates in a community in order to prevent or reduce continuous 
HIV transmissions. Mankweng is located in the Capricorn District of Limpopo 
Province. It is a rural area, which is made up of a township and six surrounding villages. 
The general academic literature on this subject, specifically in the context of rural 
Limpopo is limited. The study sought to answer two research questions: 
1. What is the proportion of adults with viral load suppression among people 
taking antiretroviral treatment for 12 months? 
2. What are the factors associated with failure to achieve viral load suppression 
among people on antiretroviral treatment for 12 months?  
The study randomly sampled medical records of patients who were on treatment for 12 
months and transferred information into a questionnaire. The study further used a 
logistic regression model to determine risk factors that alluded to failure to suppress 
viral load. Theoretical frameworks for HIV treatment adherence are revisited in order to 
further understand the interaction of ART adherence and failure to achieve viral load 
suppression. Treatment adherence is drawn from theories of psychological behaviour 
and self-regulation models. The health belief model, theory of planned behaviour and 
theory of gender and health were used to interpret findings of the study. In addition, the 
theory of change and the results chain were employed to assess the performance of the 
intervention. 
The main empirical findings are in Chapter 4 and were summarised within the 
respective of the research questions. This section synthesises the empirical findings to 
answer the study‘s two research questions. 
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1) What is the proportion of adults with viral load suppression among people taking antiretroviral 
treatment for 12 months? 
Hypothesis: There are high proportions of adults with viral load suppression among people taking 
antiretroviral treatment for 12 month. 
Viral load suppression was evident in 78 per cent of the people who were on 
antiretroviral treatment at Phela-O-Phedise primary health clinic. However, 22 per cent 
failed to achieve viral load suppression. Overall, the study refute the hypothesis that 
they were differences in demographics (age, sex and place of residence), clinical 
characteristics (baseline antiretroviral treatment, baseline CD4 count, clinical stage, TB 
co-infection and infection of other illnesses) and adherence characteristics (social 
support) between those who have achieved viral suppression and those who did not 
achieve viral load suppression. But there was significant difference in people who 
received adherence counselling and those who did not receive adherence counselling. 
2) What are the factors associated with failure to achieve viral load suppression among people on 
antiretroviral treatment for 12 months?  
Hypothesis: Multiple factors are associated with failure to achieve viral load suppression. 
The male sex has a probability of failing to achieve viral load suppression because men 
want to maintain the ‗real man‘ character. Most notably, people who are too sick (CD4 
count below 350) and those in the early stages of the disease (clinical stage I&II) are also 
likely to fail to suppress viral load. People who had other illnesses were more likely to 
fail to suppress viral load. Moreover, individuals that were prescribed 3-pill containing 
regimen and did not have any form of social support were more likely to fail to achieve 
viral load suppression. On the contrary, people who were on the advanced stage of HIV 
had less probability of failing to suppress viral load as well as people who were co-
infected with TB had less probability of failing to suppress viral load. There was no 
association between type of residence and viral load suppression. However, the 
estimates of the above mentioned risk factors were not statistically significant. 
6.2 Conclusions 
The findings show that the antiretroviral treatment intervention in Mankweng is 
successful as it achieved its intended outcome. The study shows that implementation of 
antiretroviral treatment intervention at primary health clinics in rural parts of Limpopo 
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is feasible, as it produced viral load outcomes that were comparable to other evaluation 
studies conducted in other parts of South Africa and elsewhere. The study supports the 
scale up and implementation of the intervention to other rural settings. However, the 
relatively high rates of unsuppressed viral loads is concerning in a country that is 
moving towards universal access of antiretroviral treatment. Efforts are needed to 
alleviate failure to suppress viral load for individuals who are on antiretroviral treatment.  
The findings suggest that the male sex needs focussed interventions to promote their 
early engagement into the HIV continuum of care. Further, this study highlights the 
need for early diagnosis for HIV through scaling up of the HIV testing so that the 
antiretroviral treatment can reach all those that need it. Moreover, the study identified 
risk factors that showed a trend of likelihood towards failure to suppress viral load. On 
the basis of the discussed theoretical framework the findings affirm the theory that 
failure to suppress viral load is highly associated to suboptimal adherence to treatment. 
6.3 Recommendations 
Based on the findings viral load suppression is achievable provided individuals remain 
adherent to treatment. Currently adherence counselling is offered prior to treatment 
initiation in order to psychologically prepare patients for life long treatment also in 
selective cases where the health worker suspects a case of poor adherence. However, 
theoretical arguments highlight the need for regular intensified (step up) adherence 
counselling sessions for people who are on treatment. Therefore, adherence counselling 
should be implemented more often during treatment.  
The national antiretroviral treatment guidelines recommend initiation at a CD4 below 
500 and most of the individuals had a CD4 below 350. This finding highlights possible 
variation in the use of the guidelines. Another variation in the implementation of the 
guidelines was observed in individuals who were taking three pill containing treatment 
versus one pill fixed dose treatment. Therefore, there is a need for continuous capacity 
building of health professionals on the national treatment guidelines especially when 
there are amendments.  
To generate achievable policy strategies and development targets with regards to HIV 
treatment, there is a need for more studies to allow further assessment of other 
dimensions of the intervention. Exploring the following as future research strategies can 
facilitate the attainment of the goal of universal coverage of the antiretroviral treatment 
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in order to prevent HIV transmissions as well as achievement of the UNAIDS 90-90-90 
initiative targets (an initiative to help end HIV epidemic by 2030): 
1. More research on all stages (diagnosis, linkage to care and retention) of the HIV 
continuum of care is required. 
2. The national viral load suppression targets needs to be measured inclusive of all 
the provinces. 
3. A national monitoring and evaluation system is supported by good quality data 
in order to improve the intervention and to also inform decision makers. 
Therefore, continuous mentoring and technical support of facility staff on good 
data qualities need to be provided at all the levels that generate data. 
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Appendix 1.1: Data Collection Instrument 
 
 Patient viral load monitoring  
 
1. DEMOGRAPHIC CHARACTERISTICS 
1.1 Patient Identifier  
 
 
1.2 Sex 
 Male 
 Female 
1.3 Age 
 
 
1.4 Marital Status 
Single 
Married 
Divorced 
Widowed 
Other: 
1.5 Highest education level 
Tertiary 
Secondary 
Primary 
None 
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1.6 Employment Status 
Employed 
Unemployed 
1.7 Residential area 
Rural 
Semi-Urban 
Urban 
 
2. CLINICAL CHARACTERISTICS 
2.1 Baseline CD4 cell count [cells/ul] 
 
 
2.2 Baseline WHO clinical staging 
Stage 1 
Stage 2 
Stage 3 
Stage 4 
Unknown 
2.3 TB infection 
Yes 
No 
2.4 Patient currently on  
TB treatment 
Completed treatment 
Defaulted 
2.5 Any other opportunistic infections 
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3. TREATMENT HISTORY 
3.1 ART initiation date [DD/MM/YYYY] 
 
 
3.2 Initial ART Regimen 
 
 
3.3 Current ART Regimen 
 
 
 
3.4 Any drug switch 
 
 
 
3.5 Reason for switch 
 
 
 
4. VIRAL LOAD MONITORING 
4.1 Baseline viral load [copies/ml] 
 
 
4.2 Viral load follow-up ( 12 months) 
Visit date [DD/MM/YYYY]; VL [copies/ml] 
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Visit date [DD/MM/YYYY]; VL [copies/ml] 
 
 
5. ADHERENCE INTERVENTION 
5.1 ART adherence support enrolment date [DD/MM/YYYY] 
 
 
5.2 Type of adherence support 
Adherence counselling 
Treatment buddies 
Adherence support group 
Community worker adherence group 
None 
5.3 Patient ever missed follow-up visit in the past 12 months 
Once 
Twice 
More than 3 times 
Never 
5.4 Facility reported reasons for patient‘s poor ART adherence (if any) 
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Appendix 1.2: Completed questionnaire 
 
 
 103 
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Appendix 1.3: Biosketch 
 
I, Johanna Ledwaba a Master of Management (specialising in monitoring and 
evaluation) student from University of Witwatersrand, School of governance am 
conducting this research as a partial fulfilment for my degree. 
 
I am conducting this research to assess outcomes of the antiretroviral treatment 
programme in Mankweng hospital, Limpopo province. A sponsor or any other 
organisation does not fund this study; this is solely my research under the supervision 
of University of the Witwatersrand. The research will bring no harm to any human 
being, as data will be abstracted from patient medical records. A unique patient 
identifier allocated to each patient file will be used to collect data. Therefore, patient 
names will remain anonymous, as it is not requested on the questionnaire. The 
researcher have obtained ethical clearance and granted permission to conduct the study 
by Limpopo Department of Health and the Mankweng hospital Chief Executive 
Officer. Collected data will remain confidential and the questionnaire will be filed in a 
locked cabinet. Research report will be submitted to the Department of Health to 
serve as a resource.  
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Appendix 1.4: Human Ethics Clearance certificate and   
relevant study approvals 
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